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ABSTRACT 
Nutritional Modulation of Immunity and Physiological Responses  
in Beef Calves. (August 2004) 
Michael Wayne Kurz, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Gordon E. Carstens 
 
 
 
 Twenty-four crossbred steer calves (235 + 6 kg initial BW) were weaned, 
adapted to a growing diet, trained to use Calan feeders and assigned to one of four 
treatments in a 2 x 2 factorial arrangement as follows: (1) no transit stress and saline 
injection, (2) no transit stress and trace mineral and vitamin E (TM/VitE) injections, (3) 
transit stress and saline injection and (4) transit stress and TM/VitE injection.  TM/VitE 
injections consisted of MultiminTM to provide 0.3, 0.6, 0.15 and 0.6 mg of Cu, Mn, Se, 
and Zn/kg BW, respectively, and Vita ETM to provide 9 IU of VitE/kg BW on d 0 and 21 
of the study. On d 24, transit-stressed steers were subjected to a three-d, 2000-km, 
transportation period.  During the 56-d experiment, liver and serum samples were 
assayed to assess trace mineral status, antibody titers to keyhole limpet hemocyanin 
(KLH) measured to assess humoral immunity and phytohemagglutinin(PHA)- and 
ovalbumin(OVA)-induced skin swelling and lymphocyte proliferation measured to 
assess cellular immunity.  TM/VitE-injected steers grew slower (P < 0.05) over the first 
24 d of the experiment and tended (P = 0.10) to grow slower after transit. TM/VitE 
injections increased (P < 0.05) liver Cu and Zn concentrations 135 and 21 % by d 30, 
respectively.  TM/VitE-injected steers had increased (P < 0.05) serum Cu on d 24 and 
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26, but decreased (P < 0.05) serum Zn and whole blood Se compared to saline-injected 
steers on d 24 and 56.  TM/VitE injections increased serum α-tocopherol concentrations.  
TM/VitE injections did not affect humoral immunity, but decreased (P < 0.05) skin-
swelling responses to PHA on d 21, and decreased (P < 0.05) lymphocyte proliferation 
to OVA and KLH.  Transit-stressed steers had higher (P < 0.05) serum Cu on d 26, and 
higher (P < 0.05) liver Cu concentrations on d 56 than non-transit-stressed steers.  
Transit stress did not affect serum Zn or whole blood Se concentrations.  Injections of 
TM/VitE increased Cu, Zn and vitamin E, but not Se status.  The TM/VitE treatment 
suppressed growth and cellular immune function suggesting that levels of trace minerals 
used in this study were too high. 
 
 
 
 
 
 
 
 
 
 
 
 
  v   
ACKNOWLEDGEMENTS 
 I would like to extend my sincere gratitude to Dr. Gordon E. Carstens for serving 
as my committee chair and for providing guidance throughout my graduate career.  In 
addition, I would like to extend appreciation to Dr. Dennis Herd, Dr. Thomas Welsh, and 
Dr. Surya Waghela for serving as committee members.  
I would also like to thank the wonderful group of staff and graduate students who 
worked on this experiment.  Lisa Slay, Kerry Dean, Sarah Daugherty, Casey Theis, 
Ching-Yi Chen, and Candace Moore; your countless hours of blood, sweat and tears 
have assured the completion of my degree. 
 I would like to thank my family for their gracious and never-ending support 
during this endeavor.  They have always been there to give advice and motivation during 
both the good and the bad times.  Without the support of the people who love me most, I 
would never have become the person that I am today. 
 I would like to thank my fiancée, Avery Ritter, who has lovingly supported me in 
the pursuit of this master's degree.  The sacrifices she has made during our time together 
were inspiring and will never be forgotten.  I will forever strive to reciprocate the kind of 
love and support that I receive from her. 
 
 
 
 
 
  vi   
TABLE OF CONTENTS 
 
 Page 
 
ABSTRACT ........................................................................................................ iii 
 
ACKNOWLEDGEMENTS ................................................................................ v 
 
TABLE OF CONTENTS .................................................................................... vi 
 
LIST OF TABLES .............................................................................................. viii 
 
LIST OF FIGURES............................................................................................. x 
 
CHAPTER 
  
 I INTRODUCTION....................................................................... 1 
 
 II LITERATURE REVIEW............................................................ 3 
   
  Copper Absorption and Metabolism ........................................... 3 
  Antagonists of Copper Absorption.............................................. 4 
  Enzymes Associated with Copper............................................... 6 
  Enzymes Associated with Zinc ................................................... 9 
  Physiologic Role of Selenium..................................................... 11 
  Physiologic Role of Vitamin E.................................................... 13 
  Nonspecific Immunity................................................................. 14 
  Humoral Immunity...................................................................... 16 
  Cellular Immunity ....................................................................... 20 
   
 III NUTRITIONAL AND HORMONAL MODULATION OF  
  IMMUNITY AND PHYSIOLOGIC RESPONSES TO AN  
  ENDOTOXIN CHALLENGE IN BEEF CALVES.................... 24 
 
   
  Introduction ................................................................................. 24 
  Research Objectives .................................................................... 24 
  Materials and Methods ................................................................ 25 
  Results ......................................................................................... 33 
  Discussion ................................................................................... 62 
  
 
 
 
  vii   
CHAPTER                                                                                                    Page 
 
 IV CONCLUSIONS......................................................................... 73 
 
LITERATURE CITED ....................................................................................... 75 
 
 APPENDIX ......................................................................................................... 85 
 
 VITA ................................................................................................................. 102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  viii   
LIST OF TABLES 
 
Table  Page 
 
 1 The ingredient and nutrient composition of the experimental 
  diet ................................................................................................................. 26 
  
 2 The effects of trace mineral (TM) and vitamin E (VitE) injections 
   on performance and feed efficiency in growing steers prior to  
  and following transit...................................................................................... 34 
 
3 The effects of trace mineral (TM) and vitamin E (VitE) injections 
 on body weight during transit stress and LPS challenge............................... 35 
 
4 The effects of transit-stress treatment on performance and feed  
 efficiency in growing steers prior to and following transit. .......................... 36 
 
5 The effects of transit-stress treatment on body weight during  
 transit stress and LPS challenge. ................................................................... 37 
 
6 The effects of trace mineral (TM) and vitamin E (VitE)  
injections on liver copper (Cu) and zinc (Zn)  
concentrations in growing steers. .................................................................. 39 
 
7 The effects of transit-stress treatment on liver copper (Cu)  
 and zinc (Zn) concentrations in growing steers ............................................ 41 
 
8 The effects of trace mineral (TM) and vitamin E (VitE)  
 injections on serum copper (Cu), zinc (Zn) and whole blood  
 selenium (Se) concentrations in growing steers. ........................................... 44 
 
 9 The effects of transit-stress treatment on serum copper (Cu), 
  zinc (Zn) and whole blood selenium (Se) concentrations 
   in growing steers. ......................................................................................... 45 
 
 10 The effects of trace mineral (TM) and vitamin E (VitE) 
  injections on serum α-tocopherol, γ-tocopherol, and  
  vitamin A concentrations in growing steers. ................................................. 47 
 
 11 The effects of transit-stress treatment on serum α-tocopherol 
  (α-Vit E), γ-tocopherol (γ-Vit E), and vitamin A.......................................... 48 
 
 
 
  ix   
LIST OF FIGURES 
 
Figure  Page 
 
 1 Experimental timeline ................................................................................... 27 
  
 2 Effects of TM/VitE injections on liver Cu and Zn  
  concentrations in growing steers. .................................................................. 40 
 
 3 Effects of transit-stress treatment on liver Cu and Zn  
  concentrations in growing steers ................................................................... 42 
 
 4  The effects of TM/VitE injections on change in rectal  
  temperatures (RT) after lipopolysaccharide (LPS) injection 
  in growing steers ........................................................................................... 50 
 
 5 The effects of transit-stress treatment on rectal 
  temperatures (RT) after lipopolysaccharide (LPS) injection  
  in growing steers ........................................................................................... 51 
 
 6  The effects of TM/VitE injections on antibody titer to  
  keyhole limpet hemocyanin (KLH) in growing steers .................................. 53 
 
 7 The effects of transit-stress treatment on antibody titer to  
  keyhole limpet hemocyanin (KLH) in growing steers .................................. 54 
 
 8 Effects of TM/VitE injections on phytohemmagglutinin  
  (PHA)-induced skin-swelling responses on d 21 (top graph)  
  and 35 (bottom graph) in growing steers ...................................................... 55 
 
9 Effects of transit-stress treatment on phytohemmagglutinin  
 (PHA)-induced skin-swelling responses on days 21 (top graph)  
 and 35 (bottom graph) in growing steers ...................................................... 56 
  
 10 Effects of TM/VitE injections on ovalbumin (OVA)-induced 
  skin-swelling responses on d 21 (top graph) and 35  
  (bottom graph) in growing steers .................................................................. 57 
 
11 Effects of transit-stress treatment on ovalbumin (OVA)-induced 
 skin-swelling responses on d 21 (top graph) and 35 
 (bottom graph) in growing steers .................................................................. 59 
 
 
 
  x   
LIST OF FIGURES (Continued) 
 
 
Figure   Page 
 
 
 
 12 Effects of TM/VitE injections on lymphocyte proliferation 
  to keyhole limpet hemocyanin (KLH) in growing steers .............................. 60 
 
13 Effects of transit-stress treatment lymphocyte proliferation to  
 ovalbumin (OVA) in growing steers ............................................................. 61 
 
 
 
 
  1 
CHAPTER I 
INTRODUCTION 
In order to achieve efficient growth and production of beef cattle, it is important 
to maintain herd health through proper nutrition and handling.  Because most of today's 
beef cattle are finished in a feedlot not in close proximity to the original ranch, transit 
stress is an important factor, which may affect the production and economic value of 
cattle.  Transit is an intense stressor for most cattle that involves handling, hauling, food 
and water deprivation, and sometimes changes in climate. Stressful conditions can 
impair an animal's ability to fight disease challenges.  The release of glucocorticcoids, 
such as cortisol, from the adrenal medulla has been known to reduce immune function 
by reducing lymphocyte proliferation, and decreasing cytokine production.   
Stressful conditions also induce an increase in oxidative processes that lead to 
production of a highly reactive group of compounds called reactive oxygen metabolites 
(ROM).  Reactive oxygen metabolites are also normal products of metabolism and have 
important physiologic roles such as in the respiratory burst of phagocytic cells during 
bacterial degradation.  Antioxidant mechanisms are present in the body and are 
supported by essential nutrients such as copper (Cu), zinc (Zn), selenium (Se), 
manganese (Mn), vitamin E, and vitamin A.  Some of these nutrients are cofactors for 
enzymes that reduce ROM, such as glutathione peroxidase (GSH-Px), copper-zinc 
superoxide dismutase (Cu/Zn SOD) and manganese superoxide dismutase (Mn SOD). 
This thesis follows the style and format of Journal of Animal Science. 
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Dietary trace mineral levels needed for optimal immune function are often times 
higher than the levels recommended for maximal growth or prevention of clinical 
deficiencies.  Certain minerals, such as S, Mo and Fe, have the ability to inhibit the 
effectiveness of dietary Cu, Zn, Se, and Mn by binding them in the rumen thus rendering 
them unavailable for absorption in the small intestine.  The use of an injectable trace 
mineral supplement eliminates this inhibition by providing Cu, Zn, Se, and Mn directly 
to the tissue.  The goal of this experiment is to determine the effect that antioxidant 
injection and/or transit stress will have on performance and immune function in beef 
calves. 
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CHAPTER II 
LITERATURE REVIEW 
Copper Absorption and Metabolism 
 The essentiality of copper (Cu) as a nutrient was established in the 1920s when 
Hart et al. (1928) demonstrated that supplementation with both iron (Fe) and Cu was 
required to correct anemia in milk-fed rats.  By the 1930s researchers discovered that 
cattle and sheep raised on Cu-deficient soils in Florida had high incidences of "salt 
sickness" that was remedied by Cu supplementation (Neal and Scott, 1931).  These early 
discoveries led to the general acceptance of Cu as an essential nutrient for most living 
organisms.   
 Copper is poorly absorbed by ruminants (Underwood, 1977), with a mere 5 to 
10% of total dietary copper being absorbed by adults (Symonds and Forbes, 1993).    
Although Cu can be absorbed throughout the entire intestinal tract, the primary site of 
absorption is the small intestine.  Bronner and Yost (1985) proposed that Cu absorption 
takes place by a two-step process including both active transport and simple diffusion.  
The protein metallothionine in the mucosal lining of digestive tract epithelium has been 
shown to bind Cu, and production of metallothionine has been suggested as a 
mechanism of regulation of Cu absorption (Fisher et al., 1981).  Fisher et al. (1981) 
found that copper absorption was decreased in response to high dietary zinc (Zn).  While 
metallothionine is produced in response to both Cu and Zn, the latter induces synthesis 
to a greater extent (Oestreicher and Cousins, 1985) and is thought to be responsible for 
prevention of Cu toxicity in all ruminants except sheep (Cousins, 1985).  Fisher et al. 
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(1981) hypothesized that Zn induced synthesis of metallothionine and that Cu entering 
the mucosal cell displaced Zn from metallothionine.  Since Cu was more tightly bound 
to metallothionine than Zn, the Cu was rendered unavailable for transfer out of the cell 
thereby decreasing its ability to diffuse into the portal blood.  This Cu, trapped in the 
mucosal cells, was then sloughed off to become part of the intestinal contents once more.   
 Once Cu has been actively transported into the mucosal cells of the small 
intestine, it diffuses into the blood where it binds loosely to the serum protein albumin 
and some amino acids, such as histidine, for transport throughout the body.  The primary 
storage site for Cu in cattle is the liver with concentrations ranging from 25 to 100 ppm 
DM in normal adults.  From the liver, a metalloprotein called cerruloplasmin (Cp) acts 
as a carrier to deliver Cu to target cells. Wirth and Linder (1985) found that Cp is a 
globular protein, which contains 6 to 8 atoms of Cu and accounts for 80 to 90% of total 
blood Cu.  In most species, bile is the primary excretory route for Cu, although small 
amounts may be excreted through urine, milk and feces (Underwood, 1977). 
Antagonists of Copper Absorption 
 Understanding the antagonistic effects of inorganic constituents such as sulfur 
(S), molybdenum (Mo), and Iron (Fe), are key factors to consider in Cu absorption, 
storage, and transfer.  These metals can influence the Cu status of an animal shifting it 
from deficient levels to toxic levels during consumption of an all-natural diet (Suttle, 
1991).  Copper deficiencies are classified as being either primary or secondary.  Primary 
deficiencies result from inadequate intake of dietary Cu, while secondary deficiencies 
result from ingestion of adequate levels of dietary Cu in combination with high levels of 
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antagonists.  Hardt et al. (1993) reported that 95 and 99% of bermudagrass and native 
pastures, respectively, in Texas contained < 10 ppm Cu DM.  Concentrations within a 
range of 5 to 10 ppm are considered adequate for beef cattle when no antagonists are 
present in the diet, however this situation rarely exists.  Perhaps more interesting was the 
finding that more than 50 and 35% of bermudagrass forage samples contained levels of 
S (0.32 to 0.67%) and Fe (> 200 ppm), respectively, which have been implicated in 
reducing Cu absorption.  Numerous studies have been conducted to evaluate the effects 
of S, Mo, and Fe on Cu status in calves (Genglebach et al., 1997; Wang et al., 1988; 
Bremner et al., 1987; Boyne and Arthur, 1986; Humphries et al., 1985).  Bremner et al. 
(1987) reported that Friesian steer calves fed high-Fe diets exhibited decreased liver Cu 
concentrations, which decreased further on supplementation with dietary S.  These 
authors also reported that the cattle fed a supplement containing both Fe and Mo showed 
the largest decrease in liver Cu concentration. 
 Sulfur, in the absence of Mo, may induce a secondary Cu deficiency by forming 
insoluble Cu sulfide in the rumen; however, when high levels of S and Mo are present, 
sulfate is reduced to sulfide, which reacts with Mo to form thiomolybdate (MoS4). 
Thiomolybdates bind Cu rendering it unavailable for absorption into the portal system.  
The changes that ensue effect equilibrium between the compartments and cause Cu to 
move into the plasma, thus depleting hepatic stores (Wang et al., 1988).  Studies by 
Suttle (1974) and Suttle and Field (1974) suggest that the antagonistic effects of S and 
Mo on Cu absorption take place in the rumen.  When Mo was supplemented in the diet 
and Cu administered by subcutaneous (s.c.) injection or intravenous (i.v.) infusion, the 
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antagonistic effects of Mo were alleviated.  In addition, dietary Cu was not affected by 
abomasal injection of Mo, meaning that rumen was the primary site of antagonism.  
Some MoS4 can be absorbed into the blood stream of ruminants where it complexes with 
circulating Cu by reacting with albumin.  These Cu-MoS4-albumin complexes may 
inhibit the formation of Cp in the liver (Suttle, 1991).   
In the rumen, Fe reacts with sulfate to form ferrous sulfide (FeS).  This 
interaction prevents rapid absorption of sulfide from the rumen.  The trapped sulfide is 
thought to be released in the acidic environment of the abomasum, and to react thereafter 
with Cu to form insoluble and unabsorbable CuS (Bremner et al., 1987; Suttle et al. 
1984).   
Enzymes Associated with Copper 
  Many of the clinical symptoms of Cu deficiency are due to the reduction in 
function of Cu-dependant metalloenzymes, such as cytochrome C oxidase (CCO), 
copper/zinc superoxide dismutase (Cu/Zn SOD), dopamine β-hydroxylase, and 
tyrosinase. 
Cytochrome C oxidase is the terminal enzyme in the electron transport chain, and 
is known to contain two to three Cu atoms essential for its function as a catalyst for 
oxidative phosphorylation (i.e. energy production).  Studies have demonstrated that CCO 
activity was substantially reduced in Cu-deficient mice (Prohaska, 1983) and rats 
(Prohaska and Smith, 1982).  Chao et al. (1994) reported a reduction in ATP synthase 
and CCO activity in heart tissue of Cu-deficient rats.  In sheep, reduced CCO activity 
was associated with neonatal enzootic ataxia involving incomplete myelination of 
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nervous tissue in the spinal chord (Fell et al., 1965).  As early as 1939, cattle with a 
condition called 'falling disease' were examined and diagnosed with cardiac lesions and 
extremely depressed blood and liver Cu concentrations (Bennets and Hall, 1939).  These 
clinical symptoms were comparable to those reported by Chao et al. (1994) in Cu-
deficient rats that had cardiac lesions and reduced CCO activity. 
One of the most important roles of Cu is to function as a cofactor in antioxidant 
enzymes. The major antioxidant enzyme found in the cytoplasm of cells is Cu/Zn SOD.  
Its function is to mediate the reduction of two superoxide anions (•O2-) to form one 
molecule of hydrogen peroxide (H2O2).  This reaction is crucial to cellular viability, as 
the •O2- is deleterious to cell life.  Production of reactive oxygen metabolites (ROM) 
occurs as a result of natural metabolic processes in the body.  Organisms are said to be in 
a state of oxidative stress when production of ROM exceeds the activity of antioxidant 
mechanisms.  Often, sickness or environmental stress can cause an increase in ROM 
production.  Umeki et al. (1987) measured SOD and •O2- levels in immunocompromised  
human patients with and without pneumonia, and discovered that even though all 
compromised patients showed elevated •O2- levels and decreased SOD activity, those 
compromised patients with pneumonia showed significant increases in •O2- 
concentration with a concurrent decrease in SOD function. Copper/zinc SOD is a major 
regulator of •O2- levels, and derangement of any component of the enzyme (i.e. Cu 
deficiency) may reduce the control of ROM production (Miller and Brezinskia-
Slebodzinska, 1993). 
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Copper is a component of the enzyme, dopamine β-hydroxylase, which is 
required for the production of epinephrine and norepinephrine (NE) from dopamine in 
the adrenal gland.  Both substances are important for transmission of nerve impulses, 
mediating stress responsiveness, and indirectly stimulating metabolism.  Prohaska and 
Cox (1983) found that Cu-adequate rats had higher NE concentrations than Cu-deficient 
rats, and that a Cu injection to the Cu-deficient rats reversed this effect.  Norepinephrine 
activates 5' deiodinase, which converts thyroxine (T4) to triiodothyronine (T3).  About 
90% of thyroid hormone is secreted as T4, yet T3 is four times more potent in its 
biological activity.  Compared to controls, Lukaski et al. (1995) found that deiodinase 
activity in liver and brown adipose tissue was decreased by 46 and 36%, respectively, in 
Cu-deficient rats.  Newborn lambs born to ewes fed a low-Cu diet had lower rectal 
temperatures than lambs born to ewes fed a high-Cu diet (Carstens et al., 1999).  
Additionally, the lambs from the low-Cu ewes had lower T3:T4 ratio and NE turnover 
than lambs from the high-Cu ewes.  The reduction in NE turnover and plasma T3:T4 
ratios suggest impaired stimulation of brown adipose tissue (BAT) 5' deiodinase activity 
possibly due to a reduction of dopamine β-hydroxylase stimulated production of NE.  
Copper is also a cofactor of the enzyme tyrosinase, which catalyzes the 
conversion of the amino acid, tyrosine, to melanin in hair and wool.  Copper-deficient 
cattle often have a rough coat, loss of hair pigmentation over the withers, and 'copper 
spectacles' (dilute hair color around eyes) due to reduction in tyrosinase activity (Wikse 
et al., 1992).  Liver Cu is the most reliable measure of overall Cu status, serum Cu 
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concentrations show marked decline only when liver Cu is depleted to a level below 30 
ppm DM (Hardt et al., 1991). 
Enzymes Associated with Zinc 
Zinc was recognized as an essential nutrient for mammals in the early 1930s 
based on experiments in mice and rats (Todd et al., 1934), but was not believed to be an 
essential nutrient for farm animals until 1955 (Tucker and Salmon, 1955).  Miller et al. 
(1966) reported that Zn deficiency reduced feed intake in ruminants, and that force-
feeding a ration to Zn deficient animals was fatal.  Zinc functions mostly in enzyme 
systems, so it was generally agreed that symptoms of a deficiency were manifest due to a 
reduction in the activity of some integral enzyme.  In 1970, Miller suggested that the 
enzyme must be involved in a major biochemical pathway that prevented an animal to 
utilize energy, obtain a crucial compound, or that it blocked some reaction that caused 
accumulation of toxic products.  Current research has shown that Zn is an essential 
element in key metalloenzymes such as carbonic anhydrase (CA), Cu/Zn SOD, and 
ribonucleic acid (RNA) polymerase. 
Carbonic anhydrases are widespread in nature, being found in animals, plants, 
and certain bacteria. Carbonic anhydrase plays an important role in the regulation of 
rumen pH and volatile fatty acid (VFA) absorption.  Aafjes (1967) reported that high 
concentrations of CA in the epithelium of ruminant forestomachs increased VFA 
absorption.  He stated that CO2 could be absorbed into the epithelial cells where it would 
combine with H2O in the presence of CA producing HCO3-. The production of HCO3- in 
the rumen epithelium also produced a proton gradient favorable for VFA absorption 
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(Stevens, 1970).  In fact, Wang et al. (1996) discovered that the concentration of mRNA 
that codes for the CA gene is five folds higher in mature lambs, which rely more heavily 
on rumination, compared to neonatal (pre-ruminant) lambs.   
Though Cu/Zn SOD requires both Cu and Zn for proper function, its activity is 
less dependent upon Zn status.  Rats that were fed Zn deficient diets displayed clinical 
signs of deficiency, but tissue Zn concentrations and Cu/Zn SOD activities were not 
decreased compared to rats fed Zn-adequate diets (Bray et al., 1986; Hammermueller et 
al., 1987; Taylor et al., 1988).  There was, however, an increase in production of free 
radicals by lung microsomes in Zn-deficient rats.  The actual mechanism by which Zn 
deficiency affects lung microsome free radical production is unknown; however, 
evidence suggests that zinc's role in structural integrity of tissue proteins is diminished 
during Zn deficiency (Hammermueller et al., 1987). 
  Ribonucleic acid polymerase, the enzyme responsible for the DNA-directed 
synthesis of RNA, contains two bound Zn atoms (Voet et al. 1999).  The production of 
RNA during transcription mediates the translation of this nucleic acid into specific 
proteins.  Flynn et al. (1984) suggested that Zn deficiency may have depressed 
production of key proteins responsible for proliferation, interfered with processing of 
antigens by accessory cells, or was involved in the loss of T-cell active state or function.  
James et al. (1987) found that T-cell proliferation was reduced in Zn deficient rats.  This 
study also reported a 41% reduction in thymus weight in Zn-deficient rats compared to 
controls.  This reduction may be attributed, in chronic deficiency cases (12 wks in rats), 
to a reduction in RNA processing.  Though the exact mechanism by which these 
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proliferative responses were depressed by Zn deficiency is still unknown, each of the 
cellular activities listed above involves DNA replication, involving many enzymes 
including RNA polymerase. 
Physiological Role of Selenium  
Maintenance of adequate selenium status is important for control of oxidative 
metabolism (Voet et al., 1999) and in the prevention of nutritional muscular dystrophy, 
also known as white muscle disease (WMD).  Selenium deficiency has also been shown 
to impair immune function in rodents (Mulhern et al., 1985) and calves (Swecker et al., 
1988; Droke and Loerch, 1989; Stabel et al., 1990).  
Glutathione Peroxidase. The main selenoprotein found in erythrocytes is 
glutathione peroxidase (GSH-Px); consequently, Se content is highly correlated with 
GSH-Px activity in whole blood (Miller et al., 1988).  Glutathione peroxidase was 
discovered by Mills (1957), who reported that glutathione (GSH) in the presence of this 
enzyme helped protect erythrocytes from oxidative damage by H2O2.  Rats with Se 
deficiency showed reduced GSH-Px activity compared to Se-adequate controls (Rotruck 
et al., 1972).  This lead to the discovery that GSH-Px was actually a selenoenzyme 
(Rotruck et al, 1973) consisting of four subunits each associated with one Se atom 
(Ladenstein, 1979).  Glutathione peroxidase functions by mediating the simultaneous 
reduction of H2O2 by oxidation of GSH.  Hydrogen peroxides are optimally reduced by 
GSH-Px in the cytosol prior to their incorporation into unsaturated fatty acids; therefore, 
prevention of lipid damage is the primary role of this enzyme, however, there was little 
evidence supporting the assumption that GSH-Px could reduce membrane phospholipid 
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peroxides (hydroxides incorporated into unsaturated fatty acids) (McCay et al. 1981).  
Subsequently, researchers discovered the existence of phospholipid hydroperoxide 
glutathione peroxidase (PH-GPx), an enzyme with a function analogous to that of GSH-
Px, with the obvious exception that its main substrate is phospholipid hydroperoxide 
(Weitzel et al., 1990).  The study reported a rapid decrease in GSH-Px activity during Se 
depletion (undetectable level after 130 d), with a prolonged PH-GPx activity (30 to 70% 
of controls) occurring even after 250 d.  Thus, a decrease in GSH-Px activity correlated 
to manifestation of clinical Se deficiency.  Glutathione peroxidase has been shown to 
play in integral role in immune function as well as in the early stages of inflammation 
during wound repair (Munz et al., 1997). 
Iodothyronine Deiodinase.  The iodothyronine deiodinases are selenium-
containing enzymes that catalyze the activation and inactivation of the thyroid hormones 
that regulate metabolic processes.  The deiodinase family consists of three members that 
differ with regard to their tissue distribution and their specific role in deiodination of 
thyroxine (Behne and Kyriakopoulos, 2001).  Located primarily in the thyroid, liver, 
kidney, and pituitary, type 1 deiodinase catalyzes monodeiodination of T4 at the 5' 
position of the phenolic ring producing T3 (active) or at the 5-position of the tyrosyl ring 
producing reverse T3 (inactive).  Type 2 deiodinase is expressed mainly in the 
mitochondrial membranes of brain, brown adipose tissue, and placenta (Behne et al., 
1990).  It only catalyzes 5' deiodination serving as the local regulator of T3 production in 
tissues that contain this enzyme.  Steers fed a selenium deficient diet (< 0.015 mg Se/kg) 
for 23 weeks showed a 62% increase in plasma T4 concentration with a concurrent 35% 
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decrease in plasma T3 concentration compared to controls (Arthur et al., 1988).  The 
authors suggest that this was due to suppression of iodothyronine 5'-deiodinase activity 
in Se-deficient individuals. 
Physiological Role of Vitamin E 
 Vitamin E is essential to such body functions as growth, reproduction, immunity, 
and tissue integrity (McDowell et al., 1996).  In nature, there are several forms of 
vitamin E capable of activity, the most potent being α-tocopherol with β, γ and δ-
tocopherols being 50, 20 and 10% as bioactive as the α form, respectively (Huber, 
1988).  Hoekstra (1975) reported that both vitamin E and GSH-Px are an integral part of 
the antioxidant system responsible for controlling tissue ROS and lipid peroxide levels.  
While GSH-Px functions in the cytosol of the cell, vitamin E is a highly active scavenger 
of ROS and lipid peroxides as a component of lipid membranes. 
Alpha-tocopherol as an antioxidant.  It is generally accepted that the primary 
metabolic function of α-tocopherol is to serve as an antioxidant, preventing free radical 
peroxide damage to cellular membranes (Huber, 1988).  Reactive oxygen metabolites 
can be hazardous to biological membranes by initiating chain-reactions of 
polyunsaturated fatty acids (PUFA).  Alpha-tocopherol serves to 'break' the chain-
reaction by intercepting oxygen radicals, particularly superoxide radicals.  It does this by 
reacting with the free radical carbon center of a PUFA resulting in the oxidation of the 
vitamin first to a semi-stable radical form and finally to α-tocopheryl quinone, the spent 
form of vitamin E which no longer acts as a radical scavenger (Halliwell and Gutteridge, 
1985).  The authors also suggest that there is a possible recycling of the semi-stable 
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tocopherol radical involving glutathione, glutathione peroxidase, and ascorbate (a form 
of vitamin C), resulting in the reproduction of α-tocopherol, however, the mechanism is 
still unclear at the moment.  Alpha-tocopherol acts as a radical scavenger quenching 
radicals produced in the biological membranes enabling proper cell structure, and 
ultimately, proper cell function essential for healthy bodily function. 
Non-specific Immunity 
Non-specific immunity is the body's first line of defense against invading 
pathogens and involves those cells with the ability to non-specifically phagocytize 
foreign material.  The primary leukocytes involved in this process are 
polymorphonuclear neutrophils (PMN) and mononuclear macrophages.  The mechanism 
by which these phagocytic cells destroy foreign material is called the respiratory burst 
and involves exposing engulfed bacteria to ROS. The presence of Cu/Zn SOD and 
glutathione peroxidase in the cytosol facilitates the conversion of superoxide radical to 
less harmful metabolites. 
Macrophages produce and release interleukin-1 (IL-1), interleukin-6 (IL-6), 
interleukin-12 (IL-12), and tumor necrosis factor-α (TNF-α), and are key components in 
the initiation and regulation of an immune response.  Interleukin-1 activates T helper 2 
(Th-2) cells primarily involved in the humoral immune response, acts on the brain to 
produce fever, and stimulates the liver to mobilize a pool of amino acids for the purpose 
of acute-phase protein production.  Interleukin-6 acts in much the same way as IL-1 
though is far less potent.  Interleukin-12 stimulates T helper 1 (Th-1) cells to produce IL-
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2 and interferon-α, as well as mimicking the cytotoxic activities of Th-1 cells aiding in 
the cellular immune response.  
Excess ROS production can occur during incidences of pathogenic or parasitic 
infection, transit stress, or antioxidant deficiencies (Nockels, 1996).  Immune cells are 
particularly sensitive to oxidative stress due to the high percentage of PUFA in their 
plasma membranes and the increased production of ROS, which is part of their normal 
activity (Knight, 2000).  Copper and Zn deficiency in animals has been shown to reduce 
the function of phagocytic cells. This can be associated with the decreased availability of 
the enzyme Cu/Zn SOD required for the pathogen killing ability of neutrophils and 
macrophages (Knight, 2000).  
Copper-deficient steers showed decreased Cu/Zn SOD activity as well as a fewer 
number of viable neutrophils when compared in vitro to controls (Boyne and Arthur, 
1986).  In this study, cattle were exposed to high concentrations of the Cu antagonists 
Mo and Fe, producing a secondary Cu deficiency.  The Cu-deficient cattle showed a 
decrease in the number of viable neutrophils in vitro, as well as a decreased ability to kill 
Candida albicans when compared to animals on a control diet.   In contrast, Genglebach 
et al. (1997) found no difference in ability of neutrophils from secondary Cu-deficient 
cattle to phacocytize C. albicans, and reduced pathogen killing ability by the neutrophils 
failed to reach significance (P = .15).  Feeding diets low in Cu, Jones and Suttle (1981) 
produced a primary deficiency in ewes, and reported no decrease in neutrophil killing 
ability in Cu-deficient animals.  Xin et al. (1991) reported that severe Cu deficiency in 
cattle (18 mg Cu/kg DM liver) had no effect on the phagocytic ability of neutrophils, but 
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decreased their microbicidal activity by 35%. This differs from Jones and Suttle (1981) 
and Arthington et al. (1995), who found no difference in phagocytic or microbicidal 
activity in marginally Cu-deficient ewes.  These discrepancies may provide some 
evidence that severe vs. marginal deficiency, as well as primary vs. secondary deficiency 
may affect PMN activity in a highly integrated and variable manner. 
Using cell crossover experiments in neonatal mice, James et al. (1987) 
determined that macrophages from Zn-deficient mice possessed reduced ability to 
stimulate T-cell proliferation. When macrophages from Zn-deficient mice were 
combined with control T-cells (from Zn- adequate mice), proliferative responses were 
lower compared to control macrophages combined with control T-cells.  Researchers 
suggest that this resulted from a decrease in IL-12 secretion, which is responsible for 
inducing Th-1 cell proliferation when stimulated by macrophages.  Eugui et al. (1994) 
cultured monocytes and found that pretreatment with antioxidants reduced the 
production of TNF-α and other cytokines induced by LPS challenge in vitro.  Cytokines 
are considered stimulants of ROS production, and reducing their release would decrease 
production of harmful ROS.  Webel et al. (1998) showed that plasma peak levels of IL-6 
were reduced 35% for vitamin E treated pigs compared to non-supplemented pigs, thus 
showing for the first time in vivo, cytokine relationship to antioxidant treatment.   
Humoral Immunity 
Humoral immunity involves those lymphocytes that originate in the bone marrow 
then migrate to the secondary lymphoid tissue. These lymphocytes are called B-
lymphocytes (B cells) and are involved in the production of a class of proteins called 
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immunoglobulins (Ig) that are produced to bind specifically to antigens.  There are 
currently five classes of Ig including IgG, IgM, IgA, IgD, and IgE.  In ruminants, IgG is 
the most abundant Ig in serum and is produced in large quantities when an animal is 
exposed to an antigen the second time, also known as a secondary immune response.  
The pentamer, IgM, is the second most abundant Ig in serum and is produced during 
both a primary and secondary immune response, though its presence is masked by the 
large increase in production of IgG during a secondary response.  One of the purposes of 
the antibodies is opsonization of the invading pathogen.  Opsonization is simply the 
binding of antibodies to their specific antigen on the invading pathogen causing it to be 
"tagged" for destruction by the non-specific immune cells. 
The effects of trace minerals on rodent humoral immunity have been well 
documented.  Perinatal copper deficiency in C58 mice during the first six postnatal 
weeks resulted in splenomegaly and thymal atrophy (Prohaska and Luckasewycz, 1983).  
Researchers suggest that decreased developement of the thymus in Cu-deficient mice 
could result in altered T cell subsets.  In fact, Lukasewycz et al. (1985) determined that 
when a Cu-deficient splenomegaly was observed, there was a large increase in the 
number of B cells, while T cell counts remained equivalent to controls.  Additionally, 
Prohaska and Luckasewycz (1989) found larger spleens and smaller thymus glands in 
Cu-deficient Swiss albino mice as well.  They also reported a decrease in the number of 
IgM-secreting cells in response to sheep erythrocytes in animals with moderate to severe 
Cu deficiency.  Flynn (1984) suggests that a zinc deficiency may alter lymphocyte 
responsiveness and active site functionality, therefore, depressing proliferative 
  18 
responses.  In fact, Zn tissue concentrations in the thymus and liver of mice decreased 
following sensitization of the humoral system with sheep erythrocytes (Verbanac et al., 
1998).  Lymphocyte membrane-specific functions, such as antigen recognition and 
binding, functioning receptors for cytokines and T cell adherence are affected by 
membrane fluidity and physical state, both of which are determined by the lipid acyl 
chain profile of the membrane.  Importantly, these properties are affected by ROS-
induced modification, and consequently, any mechanism in place to regulate ROS 
activity and production can improve the function of these cells (Knight, 2000).  For this 
reason, Se and vitamin E are important, as they are directly responsible for control of 
lipid peroxidation in and around cellular membranes. 
While trace mineral deprivation consistently impairs humoral immune function 
in rodents, evidence that this occurs in cattle is less consistent and highly variable.  Ward 
and Spears (1999) reported that Cu deficiency alters immune response in seven month-
old angus steers only after extended periods, and suggest that the immune system of 
cattle is not as sensitive to the adverse effects of supplemental Mo as are other 
physiological systems.  In this study, 42 steer calves were determined to be copper 
deficient (0.55 + 0.05 mg/L plasma Cu) prior to injection of 22 of these steers with 90 
mg of Cu as copper glycinate 28 d prior to weaning.  Treatments were assigned with 
factors being 0 or 5 mg Cu, as copper glycinate, per kg of DM and 0 or 5 mg Mo, as 
Na2MoO4, per kg of DM.  The steers were kept in their prior Cu treatment groups 
respectively, and ship stressed by transporting 2.5 h and holding an additional 9.5 h on 
trailers.  Cu status had no effect during the receiving (arrival of steers) phase, but Cu 
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supplementation altered immune function during growing phase variably.  Copper 
supplementation increased humoral response to ovalbumin during the growing phase (P 
< 0.10), and increased antibody titers to porcine erythrocytes in cattle that were ship 
stressed, but decreased antibody titers to porcine erythrocytes of unstressed cattle (P < 
0.05).  Additionally, despite Mo supplementation depressing Cu status during the 
growing phase, it had no effect on humoral immune function.  Branum (1999) reported 
no difference in antibody titers to a primary injection of KLH in calves whose dams 
were supplemented prenatally with 0, 20, 40 or 80 ppm Cu DM.  However, 14 d after the 
secondary inoculation, calves born to 0-Cu cows had higher KLH antibody titers 
compared to calves from 80-Cu cows.  A post-weaning diet of 0, 10 or 40 ppm Cu DM 
fed to the same calves showed that animals receiving 0 ppm Cu DM had lower IgG 
response to OVA than those fed 10 and 40 ppm Cu DM (Davis, 1999). 
Stanton et al. (1998) reported that treatment with trace minerals did not 
significantly affect the humoral immune response to IBR and PI3.  Steers were divided 
into three groups receiving different trace mineral treatments (1) Control- low level of 
supplemental trace minerals; (2) Inorganic- supplemental trace minerals from zinc 
sulfate, manganese sulfate, copper sulfate and cobalt carbonate at isomineral levels to 
treatment 3; (3) Organic- supplemental trace minerals from zinc amino acid complex, 
manganese amino acid complex, copper amino acid complex, and cobalt glucoheptonate 
per steer per d.  Despite the fact that supplementation with trace mineral either 
maintained or increased liver concentrations of each mineral, IBR and IP3 titers were not 
different in any of the groups receiving various treatments.  However, it did appear that 
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IBR titers were numerically, higher (P > 0.05) for the inorganic and organic treatments 
compared to controls. 
Droke and Loerch (1989) reported that injection of Se and/or vitamin E does 
increase antibody titers.  Steers injected with 25 mg Se (as Na2SeO3) plus 340 IU 
vitamin E had higher titers to Pasteurella heamolytica on d 7 and 14 than non-injected 
steers.  In a subsequent trial, steers that were injected with 25 mg Se plus 340 IU vitamin 
E showed increased titers to P. heamolytica compared to those that received either no 
supplement or 340 IU vitamin E alone, however titers were not different from those 
supplemented with 25 mg of Se alone.  Conversely, in a following trial, there was no 
difference in titers to P. heamolytica in steers receiving 25 mg Se plus 340 IU vitamin E 
as compared to those receiving no supplementation.  Selenium alone or in combination 
with vitamin E improved immunocompetence over animals receiving no supplement or 
vitamin E alone as evidenced by large increases in IgG titers in response to P. 
heamolytica injection.  However, the variability in the results obtained in each trial 
indicates that no firm conclusions can be drawn as to the effects of supplementation on 
the humoral response to a particular antigen. 
Cellular Immunity 
The cellular, or cell-mediated, immune response involves those lymphocytes that 
originate in stem cells of the bone marrow, and then migrate to mature within the thymus 
gland.  They are named T cells based on their location of maturation and consist of Th-1, 
Th-2, and cytotoxic T (Tc) cells. 
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Lectins, a plant-based family of proteins, are often used as mitogens in order to 
study cellular immunity.  By definition, a mitogen is a molecule that stimulates cell 
division. Most mitogens are specific for either B cells or T cells, though some 
nonspecific mitogens stimulate both cell types.  Though the mitogens 
phytohemagglutinin (PHA) and concanavalin A (Con A) are primarily T cell stimulators, 
they often have a slight effect on B cells.  Pokeweed mitogen (PWM) is a nonspecific 
mitogen with the ability to stimulate both types of cells and B cell-dependant antibody 
production.  The simplest test of lymphocyte responsiveness is the in vivo skin-swelling 
test.  In this test, the mitogen of choice is injected intradermally, and change in skin 
thickness is measured over time.  The resultant skin swelling is similar to type IV 
hypersensitivity, though peak swelling occurs some period of time after injection.  The 
delay in time needed for T cells to migrate to the injection site is the reason the reaction 
is called a delayed hypersensitivity reaction.  Lymphocyte responsiveness can also be 
assessed in vitro by counting labeled lymphocytes produced after incubation.  Purified T 
cells are cultured with an antigen or mitogen added for 48 to 96 hours.  Tritium-labeled 
thymidine is added to the culture in order to assess the amount of proliferation.  
Lymphocytes that are not proliferating do not incorporate the labeled thymidine, but 
dividing lymphocytes incorporate the thymidine into newly synthesized DNA. 
Effects of mineral deficiencies on cellular immune response to mitogens have 
been widely studied in non-ruminants using both in vivo and in vitro techniques.  Copper 
deficiency in rats and mice has been shown to reduce the number of Th cells and Tc cells 
(Bala et al., 1991; Mulhern and Koller, 1988; Lukasewycz et al., 1985).  Furthermore, 
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there was also a reduction in proliferative response to mitogens during Cu deficiency 
(Bala and Failla, 1992; Bala et al., 1991; Lukasewycz et al., 1985).  Bala and Failla 
(1992) suggest that reduced responsiveness is due to the inability of Th-1 cells to 
produce adequate IL-2 during Cu deficiency, and reported that Cu repletion restored IL-
2 production after one week.  James et al. (1987) reported that long-term Zn deficiency 
(< 0.2 µg/g dietary Zn for 12 wks) reduced the ability of T-cells to proliferate when 
stimulated by control macrophages in cell crossover experiments.  The authors state that 
the competence of the peripheral T cells would be affected when the half-life of the 
average T cell is exceeded by the duration of deficiency and thus the pool of competent 
cells becomes depleted.  The ability of Zn-deficient macrophages to stimulate T cell 
proliferation, not a decrease in T cell function, was observed due to a short-term Zn 
deficiency (6 wks).   
Direct relationships between trace mineral status and cellular immune function in 
ruminants have been less evident than in non-ruminant models.  Ward and Spears (1999) 
reported that dietary Cu treatment and transit stress had minimal effect on delayed type 
hypersensitivity (DTH) reaction to dinitrochlorobenzene (DNCB) with Cu 
supplementation lowering DTH in unstressed steers, and increasing DTH in stressed 
steers.  Branum (1999) reported that skin-swelling response to intradermal PHA was 
higher for calves born to cows fed 80 ppm Cu DM, compared to calves born to cows fed 
0, 20, and 40 ppm Cu DM.  Skin-swelling response to KLH was not different among any 
treatments, but those calves born to cows consuming the 40- and 80-Cu diets showed a 
greater decline in swelling from the maximum (12 h post injection) to the 48 h 
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measurement compared to calves from 0- and 20-Cu cows.  Davis (1999) reported that 
calves from cows receiving 0-, 20-, and 40-Cu and subsequently fed 40 ppm Cu DM had 
the highest numerical skin-swelling response and did not statistically differ from each 
other.  Calves from cows with 0-Cu and fed 0-Cu postweaning had the lowest skin-
swelling responses.   
 Stanton et al. (1998) reported that skin-swelling response to PHA injection in 
cattle was not different between inorganic and organic trace mineral treatments through 
24 hours post injection.  However, in the group receiving the high level of inorganic 
mineral treatment, there was greater skin thickness at 48 h post injection compared to 
controls.  The authors stated that it appeared that the high levels of inorganic trace 
mineral stimulated cellular immune response compared to controls.  This is in contrast to 
what the authors subsequently report that no difference in skin swelling response to PHA 
inoculation among steers recieving high levels of organic or inorganic trace minerals 
was observed compared to controls (Stanton et al., 2000). 
 Stabel et al. (1990) added sodium selenite (Na2SeO3) (from 0 to 3200 ng • mL-1) 
to bovine lymphocytes after they were incubated with Con-A, PHA, or PWM.  Optimal 
enhancement of stimulation to PWM (T- and B cell mitogen) occurred with the addition 
of 50 to 400 ng Na2SeO3 • mL-1 to the culture medium while the T cell mitogens (Con A 
and PHA) were minimally affected by Se repletion.  Researchers suggested that the 
enhancement of proliferation in PWM cultures resulted from increased production of 
cytokines such as IL-1 and IL-2 by Th cells.    
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CHAPTER III 
NUTRITIONAL MODULATION OF  
 
IMMUNITY AND PHYSIOLOGICAL RESPONSES  
 
IN BEEF CALVES  
 
Introduction 
Feedlots are often located great distances from ranches of beef cattle producers, 
which means that cattle will need to be transported at some point in time during growth 
and development.  During these long journeys adverse weather conditions, fasting, 
crowding and contact with other infected animals places greater economic importance on 
immune function of these cattle.  It is important to understand the effect that transit 
stress has on steers after they leave the ranch.  Transporting steers causes oxidative stress 
that can cause cellular and tissue damage.  This cellular and tissue damage can be 
detrimental to immune function by disrupting the control of expression of various 
cytokines, and inhibiting the ability to produce functional lymphocytes and antibodies 
(Knight, 2000).  In order to combat the detrimental effects of oxidative stress, it is 
important that cattle maintain adequate levels of antioxidants.  The trace minerals Cu, 
Zn, Se and vitamins A and E act as antioxidants and as cofactors for important enzymes 
with antioxidant activity. 
Research Objectives 
The primary objective of this experiment was to determine if injections of the 
supplemental the trace minerals Cu, Zn, Mn, Se and vitamin E prior to transit stress 
would affect humoral and cellular immunity in growing calves.  The secondary objective 
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of this experiment was to determine the trace mineral and vitamin E states of calves in 
response to injections with MultiminTM and vitamin E. 
Materials and Methods 
Experimental Design 
 Twenty-four crossbred steer calves were weaned, adapted to a growing diet, and 
trained to eat from Calan electronic gate feeders for 28 d.  Steers were assigned to pens 
equipped with Calan gate feeders (6 steers per pen) located at the Nutrition Physiology 
Center (NPC), Texas A&M University, College Station, Texas.  This facility contained 
6.1 x 12.2 m pens with a cement floor and a roof that covered approximately half of the 
pen area.  The diet (Table 1) was formulated to meet protein and energy requirements for 
steers to gain 0.7 kg/d (NRC, 2000).  Supplemental Cu, Zn, Se and vitamin E were not 
added to the diet, but 0.3% S and 900 ppm Fe (DM Basis) were added to partially impair 
copper absorption.   
Steers were blocked by BW and randomly assigned to one of four treatments in a 
2 x 2 factorial arrangement as follows: (1) no transit stress and a saline injection, (2) no 
transit stress and a trace mineral and vitamin E (TM/VitE) injection, (3) transit stress and 
a saline injection and (4) transit stress and a TM/VitE injection.  The timeline for 
TM/VitE injections in cattle is shown in Figure 1 and includes immune function 
experiments.  The TM/VitE supplement was administered on d 0 and 21 of the 
experiment and consisted of s.c. Multimin™ injections at a dose of 0.03 mL/kg of BW to 
provide 0.3, 0.6, 0.15 and 0.6 mg of Cu, Mn, Se, and Zn/kg of BW, respectively, and s.c. 
injections of vitamin E (Vita E™) at 0.03 mL/kg BW in order to provide 9 IU of vitamin  
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Table 1. The ingredient and nutrient composition of the experimental diet. 
Ingredient  Amount, % (as fed) 
   
Cottonseed hulls  45.91 
Alfalfa hay  10.0 
Cottonseed meal  18.0 
Corn, whole  16.0 
Molasses  8.0 
Calcium sulfate  1.25 
Salt  0.5 
Iron sulfate  0.34 
   
Nutrient*  Amount, % (DM basis) 
   
NEm Mcal/kg  1.52 
NEg Mcal/kg  0.92 
CP, %  18.7 
ADF, %  30.9 
K, %  1.67 
Ca, %  0.94 
S, %  0.57 
P, %  0.53 
Fe, ppm  1540.0 
Zn, ppm  50.0 
Cu, ppm  19.0 
Mn, ppm  36.0 
Mo, ppm  1.7 
Se, ppm  0.32 
*Nutrient analysis obtained from DHIA Forage Testing Laboratory, Ithaca, NY 
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   Figure 1.  Experimental timeline.  TM/VitE steers were injected with MultiminTM to 
provide 0.3, 0.6, 0.15 and 0.6 mg of Cu, Mn, Se, and Zn and 9 IU of vitamin E/kg of BW 
on d 0 and 21 of the experiment.  
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E/kg of BW.  Those calves not receiving trace mineral supplement were injected s.c. 
with an equal volume of saline. 
On d 24 of the experiment, the transit-stressed steers were transported 813 km to 
the Amarillo Research and Extension Center and held overnight with access to water 
only.  The following day steers were transported to the Uvalde Research and Extension 
Center (777 km) where they received access to hay and water overnight before being 
transported 408 km back to College Station.  The non-transit-stressed steers remained at 
the NPC in College Station.  During the three-d transit-stress period, the non-transported 
calves that remained in College Station were exposed to harsh weather conditions 
including heavy rain, strong winds and a 20 °C decrease in air temperature. 
The day after return of the transit-stressed cattle (d 27), all steers were fitted with 
a jugular cannula.  The following day (d 28) steers were administered lipopolysaccharide 
(LPS) from Escherichia coli O55:B5 (Sigma, St. Louis, Missouri) at 0.2 µg/kg of BW 
with 5 mL of buffered saline according to Elsasser et al. (1996). Rectal temperatures 
were measured at 0, 0.5, 1, 2, 4, 6, 10, 12, and 48 h during LPS challenge.  On d 28 steer 
# 123 died 8 h after inoculation with LPS and the data for this animal was removed from 
further analysis. 
 Liver Mineral Status 
Liver biopsies were performed on d 0 and 56 as well as 48 h after LPS challenge 
(d 30) using a biopsy probe (Sontec Instruments, Englewood, California).  After a 25 
cm2 area was clipped with a #40 surgical blade and surgical prep was performed, 5 mL 
of lidocaine hydrochloride (VEDCO, St. Joseph, Missouri) was injected s.c. as a local 
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anesthetic.  An incision was made in the 11th intercostal space, and the biopsy probe was 
inserted through the peritoneum and into the liver to obtain a sample (~0.2 g).  Liver 
samples were then stored at -20° C until they were freeze-dried, digested and analyzed 
for liver mineral content using flame atomic absorption spectrophotometry (Thermo-
Jarrel Ash model S11, 1990). 
Serum Mineral Status 
 Blood samples were obtained via jugular venipuncture on d 0, 24, 26, 30, and 56, 
centrifuged, serum harvested, and stored at -20° C until samples were analyzed.  Copper 
and Zn determination was preformed by diluting two mL of serum with an equal volume 
of phosphate buffered saline (PBS).  Serum Cu and Zn concentration was then 
determined using flame atomic absorption spectrophotometry (Thermo-Jarrel Ash model 
S11, 1990) and results reported in mg/L.  Blood was harvested via jugular venipuncture 
into evacuated tubes at 0, 24, 26, 30, and 56 d, and sent to Veterinary Medical 
Diagnostic Laboratory (TVMDL) Texas A&M University for analysis of whole blood Se 
concentration using atomic absorption spectrophotometry equipped with a hydride 
generator. 
Serum Vitamins 
 Blood samples were obtained via jugular venipuncture on d 0, 24, 26, 35, and 56, 
centrgifued, serum harvested, and stored at -20 °C.  Serum samples were analyzed for α-
tocopherol, γ-tocopherol, and vitamin A concentrations by Central Analytical 
Laboratory, University of Arkansas (Fayettville, Arkansas), and reported in µg/mL. 
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Humoral Immunity 
 A diluted keyhole limpet hemocyanin (KLH) (Calbiochem, San Diego, 
California) and ovalbumin (OVA) (Sigma) inoculum was prepared by diluting one mg 
KLH and four mg of OVA with two mL of PBS in saponin.  Steers were administered 
two mL of this KLH/OVA inoculum i.m. on d 0 and a booster injection on d 35.  Blood 
samples were taken via jugular venipuncture into evacuated tubes on d 0 prior to initial 
KLH injection and on d 14, 21, 35, 42, 49, and 56.  Serum was harvested and stored at -
20 °C until ELISA procedures were used to determine the antibody titer to KLH.  ELISA 
was performed by coating 96-well flat-bottom plates with 500 ng KLH/100 µL of 0.06M 
carbonate buffer (pH 9.6) per well and incubating at room temperature for 24 h.  The 
plates were then washed with 0.01M PBS (pH 7.4) containing 0.5% Tween 20 three 
times prior to blocking with a 1% casein in PBS-Tween solution.  The plates were 
washed again using the same procedure and stored at -20 °C until needed.  Serum 
samples were double diluted from 1:400 to 1:6400 in PBS.  Positive and negative 
controls and duplicate samples were added at 100 µL per well to the KLH coated plates 
and allowed to incubate at room temperature for 2 h.  The washing procedure was then 
repeated three times and 100 µL/ well of horseradish peroxidase conjugated rabbit anti-
bovine IgG (Sigma, St. Louis, Missouri) diluted at 1:30,000 with PBS was added and the 
plate allowed to incubate at room temperature for 1 h.  The plates were washed three 
times and 100 µL of ABTS was added to each well and allowed to stand at room 
temperature for 10 min before measuring absorbance at 405 nm in a microplate reader. 
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Percent positivity was calculated for each sample by dividing the unknown sample 
absorbance by the absorbance of the positive control and multiplying by 100. 
Cellular Immunity 
 A KLH and OVA inoculum was administered on d 0 and 35 (see Humoral 
Immunity).  Cellular Immunity was assessed by measuring skin reaction on d 21, 35, and 
56 to intradermal injections of 0.1 mL of  1.5 mg phytohemagglutinin (PHA) (Sigma) 
per mL of PBS and 0.1 mL of a 0.5 mg OVA per mL of PBS i.d. at one site per mitogen 
just posterior to the scapula.  Injection sites were prepared by clipping a square area with 
a #40 surgical clipper blade and measuring initial skinfold thickness using microcalipers.  
Each site, scrubbed with betadine followed by 70% isopropyl alcohol, was then injected 
with its respective mitogen. Skin swelling responses to the injection were measured at 4, 
8, 12, and 24 h with the microcalipers.  The data is reported as an increase of skin-fold 
thickness (mm) in relation to skin thickness prior to injection. 
Lymphocyte Proliferation 
 Blood samples were obtained via jugular venipuncture on d 0, 21, 28, 35, and 56 
into 10-mL evacuated tubes containing heparin.  Samples were stored at -4 °C until 
peripheral blood mononuclear (PBMC) cells were obtained by gradient centrifugation 
using Histopaque-1077.  Isolated PBMC were washed twice in heparin buffered saline 
solution (HBSS) and resuspended in RPMI complete (RPMI supplemented with 20 
IU/mL penicillin, 100 µg/mL streptomycin, 2.5 µg/mL amphotericin B, 10% FCS, 2 mM 
L-glutamine, and 0.1 mM b-ME).  PBMC (100 ul; 1 x 106 viable cells per mL) were 
added in triplicate to 96-well round-bottom tissue culture plates containing 100 µL of the 
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RPMI complete.  Ten µL of diluted KLH was added to each well in order to stimulate 
lymphocyte proliferation.  Unstimulated wells were included as controls.  The final 
volume of each well was 210 µL.  Plates were incubated in 5% CO2 at 37° C for 5 d 
before addition of 1 µCi of 3H-methylthymidine to each well.  After a further 16 h 
incubation, cells were harvested and the amount of thymidine incorporation (counts per 
minute, c.p.m.) was measured by liquid scintillation counting.  The same procedure was 
used to determine lymphocyte proliferation to PHA and OVA.  The data was reported as 
stimulation index (S.I.) calculated by dividing the sample cell counts with the negative 
control cell counts. 
Statistical Analysis 
 Data from liver Cu and Zn, serum Cu and Zn, whole blood Se, vitamin E, 
vitamin A, humoral immunity, cellular immunity, lymphocyte proliferation, and rectal 
temperature were analyzed using the mixed model with repeated measures procedure of 
SAS (2000).  The model included main effects of TM/VitE treatment, transit-stress 
treatment and day.  There were no TM/VitE treatment x transit-stress treatment 
interactions, therefore data for the main effects of TM/VitE treatment and transit-stress 
treatment were presented separately.   Weight gain, intake, growth rate, and feed 
conversion data were analyzed using general linear model procedure of SAS (2000) with 
TM/VitE treatment and transit-stress treatment as main effects.  Values for parameters 
are reported as least square means and compared by least squared differences between 
main effects, and all differences with P < 0.05 are considered significant. 
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Results 
Calf Performance Data 
 Steers that received TM/VitE injections grew slower (P < 0.01), had lower (P = 
0.10) dry matter intake (DMI) and had lower (P < 0.01) feed efficiencies than saline-
injected steers during the first 24 d of the experiment (Table 2).  During the post-transit 
period (d 31 to d 56) DMI and ADG tended (P = 0.10) to be lower in TM/VitE-injected 
steers compared to saline-injected steers, although feed efficiencies were similar.  At the 
beginning of the transit period (d 24), TM/VitE-injected steers had lower (P < 0.05) BW 
than saline-injected steers, however, upon completion of transit on d 26, the TM/VitE-
injected steers tended (P = 0.07) to have retained a greater percentage of their initial BW 
compared to saline-injected steers (Table 3).  There were no TM/VitE-treatment 
differences in BW changes during the LPS challenge or over the combined transit 
stress/LPS period (d 24 to d 31). 
 There were no differences in BW, ADG, or feed efficiency for transit-or non-
transit-stressed steers throughout the entire experiment.  However, during the post-transit 
period (d 31 to d 56), non-transit stressed steers tended to consume more (P = 0.10) DM 
than transit-stressed steers (Table 4).  Upon return from transit (d 26), stressed steers had 
lower BW (P < 0.05) and had lost a greater percentage (P < 0.001) of their BW (8.2% 
loss) compared to non-transported animals who actually gained (1.7% gain) BW (Table 
5).   During the period between d 26 and d 31, non-transit-stressed steers tended to lose a 
greater (P = 0.07) percentage of total BW when compared to transit-stressed steers.    
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Table 2.  The effects of trace mineral (TM) and vitamin E (VitE) injections on 
performance and feed efficiency in growing steers prior to and following transit. 
 
 
Item 
Saline-
injected 
TM/VitE-
injected†
 
SE 
 
P-value 
Body weight, kg     
Day 0 235.8 234.1 6.0 0.84 
Day 24  271.0 249.2 7.4 0.04 
Day 31 250.0 235.8 7.9 0.20 
Day 56 290.1 269.3 8.8 0.09 
     
ADG, kg/d     
Day 0 - Day 24 1.46 0.625 0.18 0.003 
Day 31 - Day 56 1.54 1.28 0.11 0.10 
     
Daily intake, kg DM/d     
Day 0 - Day 24 7.90 7.25 0.25 0.06 
Day 31 - Day 56 8.98 8.01 0.41 0.10 
     
Feed efficiency, g  gain/kg DM     
Day 0 - Day 24 182 86.5 0.02 0.006 
Day 31 - Day 56 174 163 0.01 0.58 
   †TM and VitE injections were administered on d 0 and 21 of the experiment. 
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Table 3.  The effects of trace mineral (TM) and vitamin E (VitE) injections on body 
weight during transit stress and LPS challenge. 
 
 
Item 
Saline-
injected 
TM/VitE-
injected†
 
SE 
 
P-value 
Body weight, kg     
Day 24  271.0 249.2 7.4 0.04 
Day 26 257.8 244.7 6.7 0.16 
Day 31 250.0 235.8 7.9 0.20 
     
     
Change in BW, %     
Day 24 - Day 26 -4.7 -1.7 1.2 0.07 
Day 26 - Day 31 -2.8 -3.6 1.5 0.69 
Day 24 - Day 31 -7.6 -5.4 1.4 0.23 
   †TM and VitE injections were administered on d 0 and 21 of the experiment. 
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Table 4.  The effects of transit-stress treatment on performance and feed efficiency in 
growing steers prior to and following transit.  
 
 
Item 
Non-transit 
stress 
Transit- 
stress†
 
SE 
 
P-value 
Body weight, kg     
Day 0  235.7 234.2 7.1 0.85 
Day 24  259.3 260.7 7.1 0.89 
Day 31 250.1 235.7 7.6 0.56 
Day 56 287.2 272.2 8.2 0.22 
     
ADG, kg/d     
Day 0 - Day 24 0.983 1.10 0.18 0.64 
Day 31 - Day 56 1.43 1.39 0.11 0.82 
     
Daily intake, kg DM/d     
Day 0 - Day 24 7.33 7.81 0.24 0.16 
Day 31 - Day 56 8.97 8.02 0.40 0.10 
     
Feed efficiency, g  gain/kg DM     
Day 0 - Day 24 130 139 0.02 0.77 
Day 31 - Day 56 159 177 0.01 0.35 
      †Steers were transported 2000 km from d 24 to d 26 and challenged with 
lippopolysaccharide between d 28 and d 31. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  37 
Table 5.  The effects of transit-stress treatment on body weight during transit stress and 
LPS challenge. 
 
 
Item 
Non-transit 
stress 
Transit- 
stress†
 
SE 
 
P-value 
Body weight, kg     
Day 24  259.3 260.7 7.1 0.89 
Day 26 263.3 239.2 6.5 0.01 
Day 31 250.1 235.7 7.7 0.19 
     
     
Change in BW, %     
Day 24 - Day 26 1.7 -8.2 1.1 0.0001 
Day 26 - Day 31 -5.1 -1.4 1.4 0.07 
Day 24 - Day 31 -3.5 -9.5 1.3 0.004 
   †Steers were transported 2000 km from d 24 to d 26 and challenged with 
lippopolysaccharide between d 28 and d 31. 
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During the LPS challenge, non-transit-stressed steers tended (P < 0.10) to lose a greater 
percentage of their BW compared to transit-stressed steers.  Overall, during the transit-
stress/LPS period, the transported steers lost a greater percentage (P < 0.01) of BW 
compared to non-transported steers. 
Liver Mineral Status 
 There was a TM/VitE treatment (P < 0.001), and TM/VitE treatment x day (P < 
0.001) interaction for liver Cu.  Liver Cu concentrations on d 0 of the study were similar 
for saline- and TM/VitE-injected steers and averaged 82.9 mg/kg DM.  Liver Cu 
concentrations were 135 and 188% higher in TM/VitE-injected steers compared to 
saline-injected steers on d 30 and 56, respectively (Table 6; Figure 2).  There was a 
TM/VitE treatment x day interaction for liver Zn. On d 0 liver Zn concentrations were 
similar for saline- and TM/VitE-injected steers and averaged 128 mg/kg DM (Table 6; 
Figure 2).  On d 30 of the study, TM/VitE-injected steers had 21% higher (P < 0.05) Zn 
concentrations than saline-injected steers.  However, by the end of the study, there were 
no treatment differences in liver Zn concentrations.     
 There was a transit-stress treatment x day interaction for liver Cu. On d 0  and d 
30 liver Cu concentrations were similar for non-transit- and transit-stressed steers and 
averaged 84 and 98 mg/kg DM, respectively (Table 7; Figure 3). On d 56 of the study, 
transit-stressed steers had 30% higher (P < 0.05) Cu concentrations than non-transit-
stressed steers.  Transit-stress treatment, but not the transit-stress treatment x day 
interaction was significant for liver Zn.  Over the entire study, transit-stressed calves had 
12% higher (P < 0.05) liver Zn than non-transit-stressed calves (Table 7; Figure 3).  
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Table 6. The effects of trace mineral (TM) and vitamin E (VitE) injections on liver 
copper (Cu) and zinc (Zn) concentrations in growing steers. 
 
Item Day 0 Day 30 Day 56 
Cu, mg/kg DM    
     Saline 79.15a 58.31a 29.47a
     TM/VitE† 89.03a 137.01b 84.89b
     SE 8.20 6.45 4.20 
    
Zn, mg/kg DM    
     Saline 135.92a 134.14a 104.23a
     TM/VitE 120.13a 161.92b 118.75a
     SE 7.47 6.68 9.46 
   abValues for each mineral within a given day with different superscripts differ (P < 
0.05). 
    †TM and VitE injections were administered on d 0 and 21 of the experiment. 
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   Figure 2.  Effects of TM/VitE injections on liver Cu and Zn concentrations in growing 
steers.  TM/VitE effect on liver Cu (P < 0.001); Day (P < 0.001); TM/VitE x day 
interaction (P < 0.001).  TM/VitE effect on liver Zn (P = 0.13); Day (P < 0.001); 
TM/VitE x day interaction (P < 0.01); there were no significant TM/VitE x transit stress 
interactions for liver Cu or liver Zn.  abValues for each mineral within a given day with 
different superscripts differ (P < 0.05). 
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Table 7. The effects of transit-stress treatment on liver copper (Cu) and zinc (Zn) 
concentrations in growing steers. 
 
Item Day 0 Day 30 Day 56 
Cu, mg/kg DM    
     Non-Transit-stressed 81.18a 92.49a 49.70a
     Transit-stressed† 87.33a 102.83a 64.63b
     SE 7.88 6.16 4.01 
    
Zn, mg/kg DM    
     Non-Transit-stressed 120.82 139.40 105.58 
     Transit-stressed 135.23 156.68 117.41 
     SE 7.19 6.38 9.03 
   abValues for each mineral within a given day with different superscripts differ (P < 
0.05). 
   †Steers were transported 2500 km from d 24 to d 26 and challenged with 
lippopolysaccharide between d 28 and d 31. 
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   Figure 3.  Effects of transit-stress treatment on liver Cu and Zn concentrations in 
growing steers.  Transit stress effect on liver Cu (P = 0.15); Day P < 0.001); Transit 
stress x day interaction (P = 0.06). Transit stress effect on liver Zn (P = 0.02); Day (P < 
0.001); Transit stress x day interaction (P = 0.93); there were no significant TM/VitE x 
transit stress interactions for liver Cu or liver Zn.  abValues for each mineral within a 
given day with different superscripts differ (P < 0.05). 
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Serum Minerals 
 The effects of TM/VitE treatment on serum Cu, Zn and whole blood Se are 
summarized in Table 8.  There was a TM/VitE treatment (P < 0.01), and a TM/VitE 
treatment x day (P < 0.001) interaction for serum Cu.  Serum Cu concentrations on d 0 
of the study were similar for saline- and TM/VitE-injected steers and averaged 1.25 
mg/L.  Serum Cu concentrations were 14 and 23% higher (P < 0.05) in TM/VitE-
injected steers compared to saline-injected steers on d 24 and 26, respectively.  
However, on d 30 and 56, there were no treatment differences in serum Cu 
concentration.  There was a TM/VitE treatment x day interaction (P < 0.01) for serum 
Zn.  Serum Zn concentrations were similar for saline- and TM/VitE-injected calves on d 
0 and averaged 1.37 mg/L.  On d 24 of the study, saline-injected steers had 37% higher 
(P < 0.05) serum Zn concentrations than TM/VitE-injected steers.  However, on d 26, 
30, and 56, there were no treatment differences in serum Zn.  The TM/VitE treatment 
had no effect on whole blood Se concentrations. 
 The effects of transit-stress treatment on serum Cu, Zn and whole blood Se 
concentrations are summarized in Table 9.  There was a transit-stress treatment x day 
interaction (P < 0.001) for serum Cu. Due to random assignment of treatments, non-
transit-stressed calves had higher serum Cu concentrations on d 0.  The effects of transit-
stress treatment on serum Cu levels were evident on d 26 (return from transit stress) 
when transit-stressed steers had mobilized 18% more (P < 0.05) Cu than non-transit-
stressed steers.  Transit stress treatment did not affect serum Zn or whole blood Se 
concentrations, and there were no transit-stress treatment x day interactions observed.  
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Table 8. The effects of trace mineral (TM) and vitamin E (VitE) injections on serum 
copper (Cu), zinc (Zn) and whole blood selenium (Se) concentrations in growing steers. 
 
Item Day 0 Day 24 Day 26 Day 30 Day 56 
Cu, mg/L      
     Saline 1.32a 0.81a 0.87a 0.86a 0.56a
     TM/VitE† 1.19a 0.92b 1.07b 0.99a 0.66a
     SE 0.05 0.03 0.04 0.80 0.03 
      
Zn, mg/L      
     Saline 1.36a 1.08a 1.26a 0.89a 1.05a
     TM/VitE 1.38a 0.79b 1.21a 0.90a 1.02a
     SE 0.05 0.05 0.05 0.05 0.04 
      
Se, µg/L      
     Saline 109.91 209.56 230.16 216.36 228.98 
     TM/VitE 98.65 210.44 174.94 209.39 182.33 
     SE 7.62 26.34 27.85 21.88 16.82 
   abValues for each mineral within a given day with different superscripts differ (P < 
0.05). 
   †TM and VitE injections were administered on d 0 and 21 of the experiment. 
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Table 9. The effects of transit-stress treatment on serum copper (Cu), zinc (Zn) and 
whole blood selenium (Se) concentrations in growing steers. 
 
Item Day 0 Day 24 Day 26 Day 30 Day 56 
Cu, mg/L      
     Non-Transit-stressed 1.18a 0.86a 0.89a 0.88a 0.58a
     Transit-stressed† 1.33b 0.87a 1.05b 0.97a 0.66a
     SE 0.05 0.03 0.03 0.07 0.03 
      
Zn, mg/L      
     Non-Transit-stressed 1.36 0.94 1.18 0.92 1.01 
     Transit-stressed 1.37 0.93 1.09 0.88 1.06 
     SE 0.05 0.05 0.05 0.05 0.04 
      
Se, µg/L      
     Non-Transit-stressed 93.48 199.72 203.48 235.15 182.95 
     Transit-stressed 115.08 220.28 201.61 190.34 228.36a
     SE 7.33 24.29 26.61 20.90 16.07 
   abValues for each mineral within a given day with different superscripts differ (P < 
0.05) 
   †Steers were transported 2000 km from d 24 to d 26 and challenged with 
lippopolysaccharide between d 28 and d 31. 
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Serum Vitamins 
 There was a TM/VitE treatment x day interaction (P < 0.001), for serum α-
tocopherol concentration.  On d 0 the mean α-tocopherol concentration was similar for 
saline- and TM/VitE-injected steers and averaged 2.5 µg/mL (Table 10).  On d 24, and 
26, the TM/VitE-injected calves had 173 and 73% higher (P < 0.05) serum α-tocopherol 
concentrations than saline-injected steers, respectively.   The TM/VitE-injected steers 
had serum α-tocopherol concentrations that averaged 24% higher (P < 0.05) than saline-
injected steers through d 56.  There was a TM/VitE treatment x day interaction (P < 
0.01) for serum γ-tocopherol concentration.  Saline-injected steers had higher (P < 0.05) 
serum γ-tocopherol concentrations than TM/VitE-injected calves on d 24 and d 26 
(Table 10).  A TM/VitE treatment x day (P < 0.001) interaction was observed for serum 
vitamin A. TM/VitE-injected steers had 35% lower (P < 0.05) serum vitamin A 
concentrations compared to saline-injected steers on d 26 of the study (Table 10).  
 The effects of transit-stress treatment on serum α-tocopherol, γ-tocopherol and 
vitamin A concentrations are shown in Table 11.  Over the entire study, transit-stressed 
steers tended to have lower (P < 0.10) serum α-tocopherol concentrations than non-
transit-stressed steers (3.47 µg/mL vs 3.82 µg/mL).  Transit-stress treatment (P < 0.05) 
affected serum γ-tocopherol concentrations, and a transit-stress treatment x day (P < 
0.001) interaction was observed.  Non-transit-stressed calves had higher (P < 0.05) 
serum γ-tocopherol concentrations than transit-stressed calves.  There was a transit-stress 
treatment x day interaction (P < 0.01) for serum vitamin A concentration.  Non-transit- 
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 Table 10. The effects of trace mineral (TM) and vitamin E (VitE) injections on serum 
α-tocopherol, γ-tocopherol, and vitamin A concentrations in growing steers. 
 
Item Day 0 Day 24 Day 26 Day 35 Day 56 
α-tocopherol, µg/mL      
     Saline 2.82a 2.82a 3.05a 2.64a 2.60a
     TM/VitE† 2.30a 7.69b 5.38b 3.27b 3.26b
     SE 0.19 0.32 0.24 0.15 0.18 
      
γ-tocopherol, µg/mL      
     Saline 0.09a 0.14a 0.10a 0.14a 0.17a
     TM/VitE 0.11a 0.05b 0.04b 0.11a 0.16a
     SE 0.01 0.01 0.01 0.01 0.02 
      
vitamin A, µg/mL      
     Saline 0.21a 0.21a 0.20a 0.21a 0.22a
     TM/VitE 0.23a 0.16a 0.13b 0.19a 0.20a
     SE 0.02 0.04 0.01 0.02 0.01 
   abValues for each vitamin within a given day with different superscripts differ (P < 
0.05) 
   *TM and VitE injections were administered on d 0 and 21 of the experiment. 
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Table 11.  The effects of transit-stress treatment on serum α-tocopherol (α-Vit E), γ-
tocopherol (γ-Vit E), and vitamin A. 
 
Item Day 0 Day 24 Day 26 Day 35 Day 56 
α-tocopherol, µg/mL      
     Non-Transit-stressed 2.97a 5.61a 4.20a 3.14a 3.18a
     Transit-stressed† 2.78a 4.89a 4.23a 2.76a 2.67b
     SE 0.18 0.30 0.23 0.15 0.17 
      
γ-tocopherol, µg/mL      
     Non-Transit-stressed 0.10a 0.10a 0.11a 0.14a 0.18a
     Transit-stressed 0.09a 0.09a 0.03b 0.11b 0.16a
     SE 0.01 0.01 0.01 0.01 0.02 
      
Vitamin A, µg/mL      
     Non-Transit-stressed 0.23a 0.22a 0.18a 0.21a 0.20a
     Transit-stressed 0.22a 0.15a 0.15b 0.18a 0.22a
     SE 0.01 0.04 0.01 0.02 0.01 
   abValues for each vitamin within a given day with different superscripts differ (P < 
0.05) 
   †Steers were transported 2000 km from d 24 to d 26 and challenged with 
lippopolysaccharide between d 28 and d 31. 
 
 
 
 
 
 
 
 
 
 
  49 
stressed steers had 20% higher (P < 0.05) serum vitamin A concentrations on d 26 
compared to transit-stressed steers.   
Immune Function 
 LPS Challenge.  The results of the LPS challenge are reported as the change in 
rectal temperature (RT) post inoculation.  The TM/VitE treatment had no effect (P = 
0.75) on change in RT during the LPS challenge (Figure 4). Peak RT for both treatments 
occurred 3 h after LPS inoculation with a mean RT increase of 1.2 °C.  A secondary 
increase (0.4 °C) in RT occurred 12 h after LPS inoculation.  There was a transit-stress 
treatment x hour interaction (P < 0.001) for change in RT during LPS challenge (Figure 
5).  Rectal temperatures for both treatment groups peaked after 3 h with a mean RT 
increase of 1.2 °C.  A secondary increase in RT was also observed 12 h after LPS 
inoculation, however, transit-stressed steers had a 300% greater (P < 0.05) increase in 
RT than non-transit-stressed steers at this time (0.8 °C vs 0.2 °C, respectively). 
Humoral Immunity.  Neither TM/VitE treatment nor transit-stress treatment 
affected humoral immunity.  The effects of TM/VitE on humoral immunity are reported 
in Figure 6, while the effects of transit-stress treatment on humoral immunity are 
reported in Figure 7.  There was evidence of a secondary immune response after the 
second injection given on d 35 when positivity values rose from 50% on d 35 to 60% by 
d 49.    
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   Figure 4. The effects of TM/VitE injections on change in rectal temperatures (RT) 
after lipopolysaccharide (LPS) injection in growing steers.  There were no significant 
differences between treatment groups. TM/VitE effect (P = 0.75); hour (P < 0.001); 
TM/VitE x hour interaction (P = 0.47).  There were no significant TM/VitE x transit-
stress interactions. 
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hour (P < 0.001); transit stress x hour interaction (P < 0.001).  †Values are different (P < 
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  Cellular Immunity.  Data taken from all steers on d 56 of the experiment showed 
abnormally hypersensitive skin-swelling response to the injected mitogens.  Data from 
this day for all steers was removed from further analysis. 
 The effects of TM/VitE on PHA cellular immune responses on d 21 and 35 are 
reported in Figure 8.  The TM/VitE-treated calves had 24% lower (P < 0.02) cellular 
immune responses to PHA compared to saline-injected steers on d 21. Treatment with 
TM/VitE did not have any affect on cellular immune response to PHA on d 35, but a 
TM/VitE treatment x transit-stress treatment x time (P < 0.05) interaction was observed.  
ean separation of the TM/VitE x transit-stress sub-classes showed that no cellular 
im
immune on d 21.  Change in mean skin-fold thickness on d 21 peaked at 5 mm for 
transit- and non-transit-stressed steers after 4 h and steadily declined for the remainder of 
the 24-h period.  Transit-stress treatment had no effect on PHA cellular immune 
response on d 35.  The effects of TM/VitE treatment on cellular immune response to 
OVA are reported in Figure 10.  TM/VitE treatment had no effect on cellular immune 
response to OVA on d 21, however a TM/VitE treatment x transit stress treatment x time 
(P < 0.05) interaction was observed.  Mean separation of the TM/VitE treatment x 
transit-stress treatment classes showed that none were different at the P = 0.05 level.  
TM/VitE injection tended (P = 0.18) to decrease cellular immune response to OVA on d 
21 with steers in the TM/VitE group averaging 30% lower responses as  
M
mune responses to PHA were different at the P = 0.05 level on d 35. 
The effects of transit stress treatment on PHA cellular immune for d 21 and 35 
are reported in Figure 9.  As expected, transit-stress treatment had no effect on cellular 
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   Figure 6. The effects of TM/VitE injections on antibody titer to keyhole limpet 
hemocyanin (KLH) in growing steers.   aValue is expressed as a percentage of a positive 
control.  Primary immunization given at d 0, with booster given on d 35. There were no 
significant differences between treatment group
Day of experiment 
s on any days. TM/VitE effect (P = 
.94); day (P < 0.0001); TM/VitE x day interaction (P = 0.07).  There were no 
ignificant TM/VitE x transit-stress interactions. 
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   Figure 7. The effects of transit-stress treatment on antibody titer to keyhole limpet 
hemocyanin (KLH) in growing steers.  aValue is expressed as a percentage of a positive 
control.  Primary immunization given at d 0, with booster given on d 35. There were no 
significant differences between treatment groups on any days. Transit stress effect (P = 
0.35); day (P < 0.0001); transit stress x day interaction (P = 0.07).  There were no 
significant TM/VitE x transit stress interactions. 
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   Figure 8.  Effects of TM/VitE injections on phytohemmagglutinin (PHA)-induced 
skin-swelling responses on d 21 (top graph) and 35 (bottom graph) in growing steers.  
TM/VitE effect on d 21 (P = 0.02); Time (P <  0.0001); TM/VitE x time effect (P = 
0.43). TM/VitE effect on d 35 (P = 0.41); Time (P < 0.0001); TM/VitE x time 
interaction (P = 0.31); there were no significant TM/VitE x transit stress interactions on 
d 21 or d 35.  †Values are different (P < 0.05). 
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   Figure 9.  Effects of transit-stress treatment on phytohemmagglutinin (PHA)-induced 
 
skin-swelling responses on days 21 (top graph) and 35 (bottom graph) in growing steers.  
Transit stress effect on d 21 (P = 0.87); Time (P < 0.001); Transit stress x time 
interaction (P = 0.71).  Transit stress effect on d 35 (P = 0.21); Time (P < 0.001); Transit 
stress x time effect (P = 0.07); there were no significant TM/VitE x transit stress 
interactions on d 21 or d 35, however there was a TM/VitE x transit stress x time 
teraction (P < 0.05) on d 35. in
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   Figure 10.  Effects of TM/VitE injections on ovalbumin (OVA)-induced skin-swelling 
responses on d 21 (top graph) and 35 (bottom graph) in growing steers.  TM/VitE effect 
on d 21 (P = 0.18); Ti
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compared to saline-injected steers.  The TM/VitE injection did not affect cellular 
immune response to OVA on d 35.  Change in mean skin-fold thickness peaked at 2.4 
mm for TM/VitE- and saline-injected steers after 4 hours and steadily declined for the 
remainder of the 24-h period.   
 Figure 11 shows the effect of transit-stress treatment on cellular immune 
responses to OVA on d 21 and 35.  Transit-stress treatment did not affect cellular 
immune responses to OVA on d 21 or d 35.  On d 21 the change in mean skin-fold 
thickness for all steers peaked at 2.3 mm after 4 hours and steadily declined over the 24-
hour period.  On d 35, the change in skin-fold thickness for all steers peaked at 2.3 mm 
after 4 h and steadily declined for the remainder of the 24-h period. 
 Lymphocyte Proliferation.  Over the entire study, saline-injected steers had 40% 
higher (P < 0.05) lymphocyte proliferation to KLH compared to TM/VitE-injected steers 
(Figure 12).  Transit-stress treatment had no effect (P = 0.8) on lymphocyte proliferation 
to KLH (Data not reported).  Figure 13 shows the main effects of TM/VitE treatment on 
lymphocyte proliferation to OVA.  Over the entire study, saline-injected steers had 70% 
higher (P < 0.01) lymphocyte proliferation response to OVA compared to TM/VitE-
injected steers.  Transit-stress treatment had no effect (P = 0.25) on lymphocyte 
proliferation to KLH (Data not reported).  Neither TM/VitE injection (P = 0.20) nor 
transit-stress treatment (P = 0.88) had any effect on lymphocyte proliferation to PHA 
(Data not reported).   
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   Figure 11.  Effects of transit-stress treatment on ovalbumin (OVA)-induced skin-
swelling responses on d 21 (top graph) and 35 (bottom graph) in growing steers.  Transit 
stress effect on d 21 (P = 0.96); Time (P < 0.0001); Transit stress x time effect (P = 
0.03). Transit stress effect on d 35 (P = 0.21); Time (P < 0.0001); Transit stress x time 
interaction (P = 0.07); there were no significant TM/VitE x transit stress interactions on 
d 21 or d 35, however, there was a TM/VitE x transit stress x time interaction (P < 0.05) 
on d 21. 
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Discussion 
Calf Performance 
 Treatment with MultiminTM Cu, Zn, Se, and Mn supplement, and vitamin E, 
reduced ADG and feed efficiency during the first 24 d of the experiment.  TM/VitE 
injectio
hat would be considered deficiency status 
ns minimally effected the percent BW change during a transit stress experiment 
and LPS challenge.  Chirase et al. (1994) found that steers fed dietary Zn (to provide 225 
mg Zn/d) for 18 d and injected with 120 mg of Cu glycinate 11 d prior to transit (2500 
km) consumed 31% less feed than steers feed supplemental Zn, but not injected with Cu 
glycenate.  Moreover, the Cu-injected steers lost more BW and regained BW slower than 
non-injected steers.  Wright et al. (1990) reported that supplementation with dietary Cu, 
Se, and Vitamin E did not affect performance of steers.  Davis (1999) reported no 
change in BW, DMI, or ADG at any time for calves fed various dietary Cu 
concentrations up to 80 ppm during the post-weaning period.  Wikse et al. (1992) 
suggested that growth might not be inhibited due to Cu deficiency unless animals are 
severely Cu deficient (< 15 ppm DM liver Cu) for an extended period of time.  The 
steers in the current study did not approach w
for either of the trace minerals examined. 
 Transit-stress treatment lowered BW and transit-stressed steers lost a greater 
percentage of total BW during transit than non-transit-stressed steers.  It must be noted 
that the transported steers received limited intake and non-transit-stressed steers endured 
harsh weather conditions during the transit-stress period.  The difference in change of 
BW percentage from d 24 to d 31 was most likely influenced by the fact that the 
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transported steers were fasted during the transit-stress period.  Transit-stress treatment 
had no effect on ADG, DMI or feed efficiency either prior to or after transportation.  
This did not agree with Kegley et al. (1997) who reported that for the first three d post-
IBRV challenge, transported steers showed decreased DMI compared to non-transported 
steers.  Subsequently, on d 17 through d 19 post-IBRV inoculation, transported steers 
showed increased DMI compared to non-transported steers.   
Liver Mineral Status 
 Trace mineral injections on d 0 and 21, increased Cu concentrations in 
livers of the TM/VitE-injected animals.  At the beginning of the experiment, liver Cu for 
all calves averaged 82.9 mg/kg DM, which fell within the adequate range of 25 to 100 
mg/kg DM (Underwood and Suttle, 1999).  By the end of the experiment, mean liver Cu 
concentrations had increased to 84.89 mg/kg DM in the TM/VitE-injected steers, 
whereas, liver Cu concentrations of saline-injected steers had decreased to 29.47 mg/kg 
 liver Cu was expected as additional S and Fe were added to DM.  The decrease in
partially impair Cu absorption.  Bremner et al. (1987) reported that steer calves feed a 
diet high in Fe showed reduced liver Cu concentrations, and that introducing S to the 
diet further decreased liver Cu concentrations.   
Liver Zn levels were adequate to high throughout the experiment for both 
TM/VitE-injected and saline-injected steers.  Liver Zn concentration for both treatment 
groups was similar on d 0 and averaged 128 mg/kg DM.  TM/VitE-supplemented steers 
had 135 and 188% higher liver Zn concentration on d 30 and 56, repectively.  Even 
though supplemented steers had higher liver Zn concentrations on d 30, both groups 
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finished the experiment with liver Zn concentrations above those considered normal 
(normal range 25 to 100 mg/kg DM).  Studies by Puls (1994) and Engle et al. (1997) 
suggest that tissue Zn level may be a poor indicator of overall Zn status.  These studies 
showed no differences in liver or plasma Zn between experimental groups fed Zn 
n (Kent and Ewebank, 1983).  Studies have 
depletion and Zn repletion diets, even when performance was inhibited.  Even though 
TM/VitE-injected calves had higher liver Zn on d 30; saline-injected calves still 
maintained adequate liver Zn concentrations.  
 Transit-stress treatment had little effect on liver mineral status.  Transit stress has 
been shown to acutely increase serum cortisol levels with peak cortisol concentrations 
occurring about 2 h following stress initiatio
shown that increases in plasma cortisol cause a concurrent increase in urinary (Henkin, 
1974) and biliary (Mearrick and Mistilis, 1969) Cu excretion.  One explanation for the 
lack of this evidence in the present experiment could be that non-transported cattle 
endured stress related to harsh weather conditions during the transit stress phase (rain 
and a 20 °C temperature drop) while in College Station.  The transported calves did not 
endure such a temperature difference, and spent 70% of the trip in dry, calm weather 
conditions.  The only difference between treatment groups occurred on d 56 when 
transported steers, had higher liver Cu concentrations (64.6 vs 49.7 mg/kg DM) than 
non-transported steers.  For this reason, it is possible that the non-transported calves 
were stressed to the same extent as the transported calves. 
No differences in liver Zn concentrations were observed between transit-stressed 
or non-transit-stressed calves on any of the observation days.  Using Zn 
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depletion/repletion trials, Suttle et al. (1982) reported that Zn levels were controlled by 
absorption and uptake, and not by excretory pathways.  The presence of adequate initial 
Zn levels, and the fact that Zn supplementation occurred via s.c. injection, could explain 
the lack of differences seen between transit-stress treatment groups. 
Serum Mineral Status 
 Serum mineral concentrations are commonly lower than plasma concentrations 
due to the possible absence of many mineral-containing proteins.  Serum Cu was well 
above the adequate levels for plasma Cu observed in Puls (1994) for
 
 the length of the 
experim
ase during periods of stress or infection (Orr et al., 1990; Chirase et 
 
ent.  Despite the saline-injected steers having low liver Cu levels of (29.7 mg/kg 
DM) by d 56, serum Cu levels were not depressed (mean d 56 serum Cu for all calves, 
0.62 mg/L) as severely as Claypool et al. (1975) reported when liver Cu levels below 40 
mg/kg consistently lowered plasma Cu levels below 0.6 mg/L.  TM/VitE-injected steers 
had higher serum Cu concentrations than saline-injected steers on d 24 and 26.  During 
this time period, the steers endured stressful conditions (half were transit-stressed, and 
the other half endured severe weather).  This agrees with research that serum Cu 
concentrations incre
al., 1991). 
Serum Zn status was not different for either TM/VitE-injected or saline-injected 
calves for all days except d 24, when saline-injected steers had higher serum Zn 
concentrations than TM/VitE (1.1 mg/L vs 0.8 mg/L, respectively).  The fact that liver 
Zn concentrations were well above adequate, and that increased variation has been found 
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betwee
dequate for all 
eatme
was caused by an induced stress response, or which group (transported vs. non-
transported) had been stressed to a higher extent.  The increase in serum Cu could be 
caused by the increased mobilization from tissue stores due to increased Cu excretion 
during catabolic and stress episodes (Cousins, 1985; Orr et al., 1990). 
n individual animal plasma Zn concentrations (Blackmon et al., 1967), could 
negate the significance of this observation.   
 MultiminTM injection provided s.c. selenium in the form of sodium selenite.  
Enjalbert et al. (1999) fed 72 Salers cows 2.5 and 45.5 mg/d selenium as sodium 
selenite.  The authors reported that sodium selenite was a highly available source and 
that increasing dietary sodium selinite increased plasma glutathione peroxidase activity.  
In the current study, whole blood Se concentration was well above a
tr nt groups, and a difference between TM/VitE- and saline-injected steers didn’t 
occur until d 56 of the experiment, when saline-injected steers (228.9 µg/mL) had higher 
Se concentration than TM/VitE-injected steers (182.3 µg/mL), still well above adequate. 
 Random assignment of transit-stress treatment resulted in transit-stressed steers 
having higher serum Cu concentrations than non-transit-stressed steers on d 0 (prior to 
injection with Multimin).  These values had equalized by d 24 (prior to transit 
departure).  Upon return from transit (d 26), transported steers had higher serum Cu 
concentration than non-transported steers (1.1 vs. 0.9 mg/L).  It should be noted that the 
steers that were not transit-stressed endured harsh cold temperatures and thunderstorms 
while remaining in their pens in College Station.  Without analyzing the change in 
cortisol levels across the treatments, it was difficult to determine whether this difference 
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Serum Zn was not different across transit-stress treatments and was well above 
adequate for the length of the experiment.  Random assignment of transit-stress 
treatment resulted in transit-stressed steers having higher whole blood Se concentration 
han non-transit stressed calves (93.5 µg/mL).  These values equalized by 
e 
copherol, so the γ-tocopherol levels were not expected to follow 
eatme
(115.1 µg/mL) t
d 24 and no difference was seen for the remainder of the experiment.  Conversely, 
Nockels et al. (1993) reported a decrease in serum Zn concentration in charolais steers 
that underwent an induced (adrenocorticotropic hormone injection) market stress 
challenge for 3 d.   
Serum Vitamins 
All calves had serum α-tocopherol levels of 2.5 µg/mL on d 0, and by d 24 
TM/VitE injection had increased α-tocopherol levels to 7.69 µg/mL, while 
concentrations from saline-injected steers remained unchanged.  As expected, TM/VitE-
injected animals maintained higher serum α-tocopherol levels throughout the remainder 
of the experiment.  
Saline-injected steers possessed increased serum γ-tocopherol on d 24 and d 26 
compared to TM/VitE-injected steers.  The form of vitamin E supplemented in th
injections was α-to
tr nt lines.  Vitamin A was not supplemented, but was analyzed in the experiment.  
The serum vitamin A concentrations were the same for both treatment groups for all 
days except d 26, when saline-injected steers had higher serum vitamin A concentrations 
than TM/VitE-injected steers (0.2 µg/mL vs. 0.13µg/mL, respectively).  
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 All calves, regardless of transit stress treatment, had the same α-tocopherol 
concentration at departure (mean serum α-tocopherol 5.3 µg/mL) and had decreased 
concentrations upon return (mean serum α-tocopherol 4.2 µg/mL) from transit stress.  
This observation could be explained by the adverse weather conditions that the non-
shipped animals experienced. Serum α-tocopherol concentrations were increased for 
non-transit-stressed steers compared to transit-stressed steers only on d 56 of the 
experiment. It has been shown that transit stress can significantly reduce the serum 
concentrations of vitamin E (Chirase et al., 2001).  In that study, animals were shipped 
om T
serum vitamin E levels when non-supplemented steers were subject to stress as 
compared to vitamin E supplemented steers.  Serum α-tocopherol concentration in the 
current study never fell below the crucial 2 µg/mL concentration.  Transit stress also 
lowered serum γ-tocopherol on d 26 and 35 and lowered vitamin A concentration on d 
26. 
LPS Challenge 
 Steers from both TM/VitE and saline-injected treatments showed increased RT in 
response to LPS inoculation.  Rectal temperature plots for both treatments groups were 
bimodal with a large peak after 3 h (1.2 °C) and a second, less intense, peak after 12 h 
fr ennessee to Texas (approximately 2500 km) and divided into the following stress 
groups: 1) simulated dust environment tent, and 2) tent without dust simulation.  Transit 
stress decreased vitamin E (α-tocopherol) concentration from 7.1 to 1.95 µg/mL (below 
the critical 2 µg/mL). This agreed with Nockels et al. (1996) who observed a decrease in 
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(0.5 °C
 1.2 and 1.4 °C.  
The au
1995) reported decreased antibody titers to B. abortus in steers 
with p
).  Transit-stress had little effect on change in RT.  Transit-stressed steers had an 
increased change in RT compared to non-transit-stressed steers 12 h after LPS 
inoculation.  The increases in RT of LPS challenged steers is similar to the results of 
Elsasser et al. (1996) who reported that mean change in basal RT of LPS inoculated 
calves peaked between 3 and 4 h after inoculation at a value between
thors stated that LPS was a valuable tool used to examine disease processes 
because it produced a gradable response that was proportional to injected dosage.  Fever 
was an important characteristic of the endotoxin administration, and the febrile response 
has been used as an accurate method to quantify the severity of the elicited condition.   
Humoral Immunity 
 Treatment with TM/VitE had no effect on antibody titer response to KLH.  
Though it is well documented in rodent studies that Cu-deficiencies cause increased 
numbers of splenic B cells due to thymic atrophy (Lukasewycz et al., 1985; Bala et al., 
1990; Prohaska and Lukasewycz, 1983), humoral immune function studies in cattle have 
been more variable. Past studies have shown that antibody titers to an antigen are 
impaired (Cerone et al., 1995), unchanged (Ward et al, 1993; Niederman et al., 1994) or 
elevated (Stabel et al., 1993) in Cu-deficient steers when compared to Cu-adequate 
steers.  Cerone et al. (
lasma Cu concentrations below 0.5 mg/L as compared to steers with adequate 
plasma Cu (> 0.9 mg/L).  Stable et al. (1993) reported a decrease in serum IgM in Cu-
deficient steers (< 0.4 mg/L plasma Cu) compared to Cu-adequate (> 0.8 mg/L plasma 
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Cu), however antibody titers to IBRV were elevated in the Cu deficient steers compared 
to Cu adequate steers.   
 Transit-stress treatment had no effect on humoral immune function in growing 
steers.  Brown-Borg et al. (1993) reported that young pigs with high baseline levels of 
plasma cortisol had a lowered immune response compared to pigs with low baseline 
cortisol levels.  The authors suggested the possibility of high/low stress predestination, 
which would influence immune function and favor those “low stress” animals over “high 
determination of base cortisol levels, or peak levels during stress” animals.  Without 
transit stress, there was no way to determine exactly how much or a stress response was 
induced.   
Cellular Immunity 
 Treatment with TM/VitE injections did not enhance cellular immune responses 
in growing steers during this study.  On d 21, saline-injected cattle had higher PHA-
induced skin swelling responses (5.3 vs 4.1 mm) compared to TM/VitE steers.  The 
PHA-induced responses on d 35 and OVA-induced skin swelling responses on d 21 and 
35 were similar for TM/VitE- and saline-injected steers. 
In rodents, it has been shown that Cu-deficiency reduced the number of Th cells 
and Tc cells in both mice and rats (Bala et al., 1991; Mulhern and Koller, 1988; and 
Lukasewycz et al., 1985).  Bala and Failla (1992) also reported a decrease in the 
proliferative responses of T cells to mitogen during Cu-deficiency, and suggested that 
this was caused by the inability of Th-1 cells to produce adequate IL-2. 
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Evidence of a clear mechanism for trace mineral effects on cellular immune 
function has been less evident in cattle.  Ward and Spears (1999) reported that dietary 
Cu treatment had minimal effect on delayed-type hypersensitivity (DTH).  Branum 
(1999) reported that calves born to cows which were supplemented prenatally with 80 
ppm dietary Cu, had increased skin-swelling responses compared to calves born to cows 
supplemented with either 0, 20, or 40 ppm author suggested that the 
immune function of calves may ha nt upon Cu status of the dam, and 
differences observed could have er development of primary and 
secondary immune organs.  In 
transient, marginal deficiency induced in saline-injected steers at the end of the study 
industrial trailer for 2.5 h.  The bulls remained on the trailer for 9.5 h in order to bring 
stressed showed increased DTH response compared to non-stressed animals.  These 
results disagree with reports that transit stress impairs immune function (Kelly, 1988).  
Kegley et al. (1997) reported no differences in percentages of neutrophils or in ratio of 
neutrophils to lymphocytes between transit-stressed and non-transit-stressed steers 7 d 
after transit stress.  The steers in the current study were evaluated for cellular immune 
 dietary Cu.  The 
ve been depende
 been due to prop
the current experiment, perhaps, either 1) trace mineral 
deficiency was not severe enough to elicit any type of immune dysfunction, or 2) the 
was not severe enough to elicit immune dysfunction due to previous proper development 
of the immune organs. 
Transit stress treatment did not affect PHA or OVA cellular immune responses 
on any of the observation days.  Ward and Spears (1999) transported angus bulls on an 
the total time on the trailer to 12 h.  Bulls that were fed supplemental Cu and transit-
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responses on d 21 and 35, and were transit-stressed between d 24 and 26 (9 d after return 
from stress). 
Lymph
e 
difference failed to reach significance.  Arthington et al. (1995) reported no differences 
in lymphocyte blasotgenesis when Cu-deficient heifers were repleted with Cu.  Stabel et 
al. (1990) added sodium selenite to bovine lymphocytes after they were incubated with 
M.  Optimal enhancement of stimulation to PWM occurred with the 
addition of 50 to 400 ng Na2SeO3 • mL-1 to the culture medium while the responses to 
e T cell mitogens, Con A and PHA were minimally affected by Se repletion.  
esearchers suggested that the enhancement of lymphocyte proliferation in PWM 
cultures resulted from increased production of cytokines such as IL-1 and IL-2 by Th 
 
 
 
ocyte Proliferation 
 Treatment with TM/VitE decreased lymphocyte proliferation to KLH and to 
OVA, but had no effect on proliferative response to PHA.  The lymphocyte proliferation 
assay is an in vitro evaluation of the cellular immune response, and the delayed-type 
hypersensitivity response measurement (skin-swelling response) is an in vivo evaluation 
of cellular immunity.  TM/VitE injection suppressed PHA cellular immune response on 
d 21, and lymphocyte proliferation to PHA on d 21 is numerically higher, though th
Con-A, PHA, or PW
th
R
cells.    
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CHAPTER IV 
CONCLUSIONS 
Treatment with MultiminTM and vitamin E increased liver Cu and Zn 
oncentration and increased serum α-tocopherol concentration in growing steers fed a 
iet containing S (0.57%) and Fe (1500 ppm).  Trace mineral supplementation decreased 
growth and feed efficiency, suggesting that the dose administered in this study was too 
high.  Many studies have exam ineral and vitamin E 
immune function was decreased.  TM/VitE-i
wellin  
 
race mineral supplementation did increase the trace mineral status of the steers in this 
study, 
ent were not initially deficient in Cu, Zn, Se or vitamin E, 
and tha
The financial losses associated with the reduced ADG and feed efficiency 
reporte  substantial when applied to feedlot economics.  
crease ; however, the effects of using 
c
d
ined the effects of trace m
supplementation on immune function; however, few have used injectable multi-source 
supplements.  While humoral immunity was not affected by TM/VitE treatment, cellular 
njected steers had decreased lymphocyte 
proliferation to KLH and OVA over the entire study and also had decreased skin-
g responses to PHA on d 21, but not d 35.  Transit stress treatment did not affects
liver or serum mineral status, but did acutely lower serum vitamin A and γ-tocopherol
levels.  Both humoral and cellular immune functions were unaffected by transit stress.  
T
however, the decreases in performance and immune function could be due to the 
t steers in the experimfact tha
t further supplementation elicited toxic effects. 
d in this experiment would be
The use of an injectable multi-source trace mineral supplement would logistically 
 the efficiency of feedlot management practicesin
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these supplements are extremely inconsistent.  Additional research is needed to better 
assess trace mineral status of animal in order to establish adequate doses of Cu, Zn, Se 
and Mn
 
 
 
 
 
 to elicit optimal physiological responses such as growth and immune function. 
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APPENDIX 
able A-1.  Individual BW (kg) of growing steers throughout experiment. 
Tran D0 D7 D14 D21 D24 D26 
21 Sal No 244 244 257 269 288 265 
T
 
Id Trt 
1
126 Sal No 220 213 220 230 224 239 
28 Sal No 251 258 259 278 280 287 
32 Sal No 262 266 269 286 296 298 
35 Sal No 229 232 251 253 259 269 
39 Sal No 216 231 234 251 268 264 
40 Sal No 247 249 265 282 292 288 
22 Sal Yes 221 236 230 256 262 227 
129 Sal Yes 266 269 280 281 279 265 
13 Sal Yes  52  28
1 Sal Yes  200 2 4 227
1 Sal Yes  231 2 9 255
1 TM/E No  230 2 2 262
1 TM/E No  212 2 8 240
1 TM/E No  257 2 9 265
1 TM  213 2 5 232
1 TM/E No  227 2 9 232
1 TM/E Yes  230 2 9 247
1 TM/E Yes  247 2 8 259
1 TM/E Yes  220 2 0 235
1 TM/E Yes  205 2 0 225
1 TM/E Yes  259 2 9 275
1 TM/E Yes  247 2 4 267
1
1
1
1
1
1
127 Sal Yes 250 269 267 279 306 259 
6 231 2  262 267 6 270 
42 192  15 21  201 
43 239  41 24  235 
30 239  45 25  268 
31 227  16 23  241 
34 253  61 26  274 
45 /E No 216  22 22  241 
47 230  33 23  245 
23 230  42 25  240 
24 250  59 25  248 
25 216  27 23  215 
33 218  13 23  212 
41 253  54 26  257 
46 239  61 26  246 
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Table A-1 (Cont.).   
 
121 Sal No 259 270 269 294 309 317 
Id Trt Tran D30 D31 D35 D42 D49 D56 
126 Sal No 219 212 223 241 239 259 
128 Sal No 273 275 282 297 308 322 
132 Sal No 280 294 292 299 319 330 
135 Sal No 234 245 251 261 272 279 
139 Sal No 241 250 259 269 288 284 
140 Sal No 260 256 271 288 295 309 
122 Sal Yes 221 219 226 238 242 247 
127 Sal Yes 258 259 281 292 290 303 
129 Sal Yes 261 273 286 303 319 322 
143 185 234 249 247 263 265 
T  No 254 261 259 276 283 288 
T  No 223 230 230 253 261 269 
T  No 259 269 274 283 295 299 
T  No 213 225 230 242 243 249 
T  No 220 229 242 258 266 267 
TM/E Yes . . . . . . 
T  Yes 220 215 244 256 260 269 
T  210 212 230 239 244 250 
T  199 201 214 209 227 228 
T  259 259 274 286 296 296 
T  259 257 259 269 274 278 
136 Sal Yes 259 263 275 286 295 308 
142 Sal Yes 211 208 207 224 237 236 
Sal Yes 
130 M/E
131 M/E
134 M/E
145 M/E
147 M/E
123 
124 M/E
125 M/E Yes 
133 M/E Yes 
141 M/E Yes 
146 M/E Yes 
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Table A-2.  Individual feed intake (kg, as fed basis) of steer throughout the experiment. 
 
Id Trt Tran D7 D14 D21 22-24 31-35 D42 D49 D56 
121 Sal No 57 61 71 31 51 84 89 86 
126 Sal No 50 46 52 25 35 62 64 71 
128 Sal No 54 52 64 26 45 78 80 83 
132 Sal No 50 53 69 30 51 79 80 79 
135 Sal No 60 68 68 31 40 61 62 70 
139 Sal No 52 50 63 27 48 74 66 69 
140 Sal No 54 65 80 34 43 75 84 87 
122 Sal Yes 53 54 70 30 27 41 48 54 
127 Sal Yes 54 50 61 27 38 57 56 63 
129 Sal Yes 53 55 65 28 44 72 79 74 
Y 51 47 45 20 51 5 2 
T  N 44 43 52 25 65 66
T  N 50 45 57 26 61 64
T  N 53 54 61 27 71 6
T  N 51 46 51 24 62 5
T  N 51 51 55 23 60 6
TM/E Yes 50 58 23 . . . 
TM/E Yes 53 57 59 29 47 52
T  Y 54 58 55 23 57 55
T  Y 53 61 64 25 56 55
T  Y 55 51 65 32 76 8
T  Y 56 61 67 30 56 5
136 Sal Yes 58 70 76 31 39 77 83 88 
142 Sal Yes 61 73 80 33 51 85 89 78 
143 Sal es  31 3 5
130 M/E o  45  66 
131 M/E o  36  73 
134 M/E o  47 9 72 
145 M/E o  45 9 59 
147 M/E o  35 5 67 
123 50  .  
124  36  59 
125 M/E es  35  59 
133 M/E es  34  58 
141 M/E es  39 0 80 
146 M/E es  36 9 55 
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Table A-3. Raw data values for liver Cu concentrations (mg/kg DM) in growing steers. 
 
Id Trt Tran Day 0 Day 30 Day 56 
121 Sal No 77.75 60.53 21.27 
126 Sal No 52.39 27.28 11.75 
128 Sal No 94.38 52.28 18.92 
132 Sal No 61.00 43.38 13.32 
135 Sal No 95.27 54.59 50.95 
139 Sal No 98.79 71.90 31.63 
140 Sal No 80.98 61.07 26.85 
122 Sal Yes 81.12 48.11 30.71 
127 Sal Yes 85.89 64.99 39.59 
143 S   7 4
TM/E 
TM/E  2.3 8 
TM/E  5.2 4 
TM/E  2.2 6 
TM/E  2.0 0 
TM/E  7.4 0 
TM/E  4.5 6 
TM/E 1  9.4 5 
TM/E  2.1 1 
TM/E  8.6 6 
TM/E 1  0.5 7 
129 Sal Yes 73.39 62.11 17.17 
136 Sal Yes 66.41 53.66 20.45 
142 Sal Yes 70.15 65.50 31.92 
al Yes
No 55.00 
93.05 8 .40 60.9  
130 
131 
108.27 
15
74.93 
76.5No 143.70 7 
134 No 97.20 10 0 86.1
145 No 72.13 17 7 64.0
147 No 36.10 12 1 64.6
123 Yes 87.31 12 0 96.5
124 Yes 74.22 18 7 99.2
125 Yes 56.94 11
12
9 90.7
133 Yes 75.60 0 80.7
141 Yes 70.71 15 9 116.4
146 Yes 13.21 6 3 21.2
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T  A w  v fo  Z /kg  co rat  g g  
 
 Id Trt Tran Day 0 Day 30 Day 56 
able -4. Ra  data alues r liver n (mg  DM) ncent ions in rowin steers.
121 Sal No 131.54 111.50 98.51 
126 Sal No 125.43 147.02 98.75 
128 Sal No 125.66 117.48 105.14 
132 Sal No 122.31 109.80 123.44 
135 Sal No 128.98 123.65 120.34 
139 Sal No 124.55 106.54 95.40 
140 Sal No 123.29 146.09 79.14 
122 Sal Yes 122.56 142.38 97.07 
127 Sal Yes 164.35 164.84 96.81 
129 Sal Yes 117.18 125.47 105.52 
136 Sal Yes 179.28 146.84 116.63 
130 TM/E  9 8
TM/E 1  9. 50
TM/E 1  5. 27
TM/E 1  6. 99
TM/E 1  3. 10
TM/E  1  3. 75
TM/E   7. 61
TM/E  1  4. 34
TM/E  9. 28
TM/E 1  182. 71
TM/E 1  1. 51
142 Sal Yes 177.35 138.75 102.90 
143 Sal Yes 117.26 155.14 109.44 
No 100.66 11 .05 122. 4 
131 No 38.41 17 32 122.  
134 No 04.92 15 44 99.  
145 No 24.40 20 05 96.  
147 No 15.41 12 11 90.  
123 Yes 23.93 16 33 238.  
124 Yes 92.90 16 36 106.  
125 Yes 93.32 17 24 110.  
133 Yes 89.64 14 03 92.  
141 Yes 19.65 82 106.  
146 Yes 25.37 11 50 98.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  90 
T  A w va or  C /L en s w er
 
Id Trt Tra
n 
D 0 D 24 D 26 D 28 D 28.5 D 29 D 30 D 56 
121 Sal No 1.34 0.754 0.86 0.95 0.84 0.93 0.78 0.62 
able -5. Ra  data lues f serum u (mg ) conc tration in gro ing ste s. 
126 Sal No 1.30 0.976 0.95 0.89 0.83 0.84 1.03 0.54 
128 Sal No 1.40 0.876 0.90 0.84 0.87 0.75 0.88 0.49 
132 Sal No 1.07 0.67 0.59 0.59 0.67 0.75 0.58 0.43 
135 Sal No 1.13 0.62 0.72 0.62 0.92 0.96 1.02 0.58 
139 Sal No 1.28 0.822 0.72 0.76 0.80 0.83 0.75 0.53 
140 Sal No 1.01 0.82 0.82 0.64 0.78 0.76 0.92 0.54 
122 Sal Yes 1.31 0.80 1.07 1.04 0.88 1.01 0.77 0.72 
127 Sal Yes 1.91 0.80 0.79 . 0.87 0.73 0.84 0.62 
129 Sal Yes 1.29 0.88 0.91 0.88 0.87 0.92 0.66 0.54 
Sal Yes 1.65 0.99 1.14 1.07 1.08 0.98 1.07 0.72 
0 /E 
 /E  0 1.68 0.92 
 /E  1 0 0.86 1.33 
 /E  1 0.87 0.95 
 /E  1.16 1 0.93 1.24 
 /E  1.34 0
 /E  1.02 1.30 1.12 1.16 1.40 
 /E  1 1.11 0.87 
 /E  1.0 1.02 0.90 
 /E  1.18 1 1 1.10 1.06 
 /E  1.35 1 1.16 1.27 
136 Sal Yes 1.33 0.87 1.06 0.91 0.76 0.91 0.75 0.57 
142 
143 Sal Yes 1.10 0.66 0.76 0.76 0.73 0.75 1.04 0.58 
13 TM No 1.16 0.93 0.96 1.23 0.74 0.89 0.65 0.58 
131 TM No 1.15 0.84 .94 1.41 0.75 0.64 
134 TM No 1.19 0.94 .03 .83 0.72 0.57 
145 TM No 1.11 1.00 .01 0.94 1.03 0.75 
147 TM No 0.95 .01 0.95 1.30 0.60 
123 TM Yes 0.76 .99 0.99 . . . . 
124 TM Yes 1.32 1.68 0.73 
125 TM Yes 1.14 0.89 .08 1.24 0.73 0.54 
133 TM Yes 1.10 0.82 8 0.93 1.20 0.67 
141 TM Yes 1.00 .18 .06 0.89 0.53 
146 TM Yes 0.98 .23 1.12 0.95 0.94 
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Table a a va  fo m Z g/L cen ns i owi teer
 
Id Trt Tran D 0 D 24 D 26 D 28 D 28.5 D 29 D 30 D 56 
121 Sal No 1.60 1.42 1.50 1.29 0.57 0.87 0.84 1.07 
 A-6. R w dat lues r seru n (m ) con tratio n gr ng s s. 
126 Sal No 1.30 1.05 1.08 1.43 0.39 0.46 0.91 1.09 
128 Sal No 1.60 1.13 1.24 1.08 0.41 0.58 0.78 0.87 
132 Sal No 1.39 1.19 1.48 1.46 0.52 0.86 0.98 1.08 
135 Sal No 1.19 0.81 0.91 1.09 0.65 0.58 1.17 0.99 
139 Sal No 1.22 0.89 0.90 1.27 0.43 0.73 0.75 0.84 
140 Sal No 1.28 1.14 1.15 0.96 0.40 0.58 1.05 0.93 
122 Sal Yes 1.32 0.92 1.29 1.00 0.60 0.59 0.54 1.02 
127 Sal Yes 1.78 1.18 1.31 . 0.43 0.51 0.93 1.38 
129 Sal Yes 1.23 1.31 1.22 1.18 0.59 0.75 0.88 1.11 
136 Sal Yes 1.26 1.11 1.37 1.05 0.47 0.79 1.05 1.08 
142 Sal Yes 1.05 0.74 1.34 0.93 0.44 0.68 0.86 1.01 
TM/E No 1.32 1.02 1.41 1.48 0.55 0.84 0.96 1.12 
134 TM/E No 1.38 0.68 1.20 1.36 0.7 .92  
TM/E No 1.47 0.78 1.23 1.25 0.51 0.8 .94  
TM/E No 1.19 0.85 1.07 1.23 0.57 1.0 .99  
TM/E Yes 1.29 0.89 1.33 1.20 . . 
TM/E Yes 1.33 0.67 1.22 1.15 0.75 0.4 .60  
TM/E Yes 1.50 0.78 1.31 1.07 0.47 0.6 .98  
TM/E Yes 1.24 0.76 1.04 1.09 0.51 0.5 .73  
TM/E Yes 1.55 0.79 1.25 1.20 0.48 0.6 .12  
TM/E Yes 1.48 0.92 1.25 1.20 0.81 1.3 .92  
143 Sal Yes 1.41 1.13 1.50 1.38 0.50 0.52 0.83 1.16 
130 
131 TM/E No 1.40 0.58 1.05 1.41 0.87 0.56 0.78 1.09 
0.53 8 0 1.06
145 0 0 1.03
147 1 0 0.96
123 . . 
124 7 0 0.93
125 2 0 0.90
133 0 0 1.00
141 9 1 0.92
146 3 0 1.16
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T  A w valu  wh d se  (ppb) concentrations in growing 
steers. 
 
Trt Tran D 0 D 24 D 26 D 28 D 28.5 D 29 D 30 D 56 
21 Sal No 101 330 247 307 252 135 286 185 
able -7. Ra  data es for ole bloo lenium
Id 
1
126 Sal No 106 248 188 91 250 225 225 229 
128 Sal No 103 225 282 121 73 228 292 224 
32 Sal No 73 243 265 210 246 271 105 210 
35 Sal No 74 117 131 245 225 315 278 254 
39 Sal No 116 99 200 234 120 213 212 219 
40 Sal No 135 103 332 279 204 200 192 127 
22 Sal Yes 124 288 81 255 . 66 261 223 
27 Sal Yes 71 229 239 61 225 250 276 293 
29 Sal Yes 77 287 253 308 . 187 206 207 
36 Sal Yes 141 98 270 216 226 211 228 223 
42 Sal Yes 161 221 334 139 110 59 102 325 
43 Sal Yes 136 226 171 221 250 65 172 235 
M/E No 86 255 273 377 142 161 223 113 
14 TM N 9 61 6 89 0 
1 10 264 76 253 271 57 
1 12 . . . . 
1 14 284 0 304 104 28 
1 11 281 81 281 188 04 
1 8 219 4 247 167 5 
1 9 191 2 287 47 9 
1 10 105 6 276 276 58 
1
1
1
1
1
1
1
1
1
1
130 TM/E No 72 235 308 331 203 297 270 96 
131 T
134 TM/E No 63 . 79 39 224 86 279 278 
5 /E o 5 11 90 256  21 140 
47 TM/E No 9 280  2 167 
23 TM/E Yes 9 191 . . 
24 TM/E Yes 4 13 173  1 109 
25 TM/E Yes 5 111  3 194 
33 TM/E Yes 7 17 85  9 243 
41 TM/E Yes 6 35 296  7 284 
46 TM/E Yes 0 15 100  2 216 
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T  A w valu  seru coph µg/m ncen
steers. 
 
Id Trt Tran D 0 D 24 D 26 D 28 D 35 D 56 
121 Sal No 3.20 3.30 3.30 3.20 3.20 3.20 
able -8. Ra  data es for m α-to erol ( L) co trations in growing 
126 Sal No 3.00 2.90 2.70 2.00 2.20 3.00 
128 Sal No 2.00 2.70 3.60 2.70 2.80 2.00 
132 Sal No 3.40 3.00 3.10 3.00 2.40 3.40 
135 Sal No 1.70 2.60 2.40 2.50 2.10 1.70 
139 Sal No 2.70 3.10 3.00 2.20 3.40 2.70 
140 Sal No 3.90 3.70 4.00 3.50 3.00 3.90 
122 Sal Yes 3.00 2.60 3.30 1.60 2.10 3.00 
127 Sal Yes 2.90 3.30 3.30 2.80 3.50 2.90 
129 Sal Yes 2.10 3.20 3.30 2.50 2.70 2.10 
136 Sal Yes 2.70 1.50 2.20 2.30 2.20 2.70 
Sal Yes 2.80 2.60 3.00 3.10 2.50 2.80 
131 TM/E No 
TM/E No 
T  
TM/E No 
TM/E Yes 
TM/E Yes 
TM/E Yes 
TM/E Yes 
TM/E Yes 
TM/E Yes 
142 Sal Yes 3.30 2.50 2.50 3.10 1.90 3.30 
143 
130 TM/E No 3.30 9.30 6.80 4.40 4.00 3.30 
2.60 9.10 6.40 3.50 3.60 2.60 
134 2.20 7.90 3.90 3.70 3.90 2.20 
145 M/E No 3.70 6.30 4.00 3.20 3.90 3.70 
147 3.80 8.60 4.90 3.20 3.00 3.80 
123 2.30 6.30 5.60 . . 2.30 
124 2.50 7.80 6.50 2.80 2.30 2.50 
125 2.20 5.60 5.00 2.80 2.50 2.20 
133 3.70 10.20 6.20 2.90 4.10 3.70 
141 2.60 6.50 5.40 3.10 2.70 2.60 
146 3.20 6.60 4.50 3.20 3.00 3.20 
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T  A w valu  seru coph µg/m cent s in g g 
steers. 
 
Id Trt Tran D 0 D 24 D 26 D 28 D 35 D 56 
121 Sal No 0.11 0.18 0.14 0.22 0.24 0.11 
able -9. Ra  data es for m γ-to erol ( L) con ration rowin
126 Sal No 0.11 0.19 0.14 0.12 0.17 0.11 
128 Sal No 0.05 0.10 0.17 0.15 0.21 0.05 
132 Sal No 0.11 0.16 0.16 0.16 0.13 0.11 
135 Sal No 0.08 0.11 0.13 0.17 0.15 0.08 
139 Sal No 0.06 0.12 0.12 0.10 0.17 0.06 
140 Sal No 0.13 0.21 0.26 0.20 0.24 0.13 
122 Sal Yes 0.11 0.12 0.04 0.06 0.13 0.11 
127 Sal Yes 0.11 0.25 0.08 0.21 0.33 0.11 
129 Sal Yes 0.05 0.12 0.03 0.10 0.13 0.05 
136 Sal Yes 0.04 0.05 0.02 0.07 0.09 0.04 
s 0.11 0.12 0.06 0.13 0.16 0.11 
131 TM/E No 0.13 0.04 0.04 0.11 0.24 0.13 
TM/E No 0.0 0.05 .13  
T  
TM/E No 0.12 0.05 0.06 0.13 0.11 0.12 
TM/E Yes 0 0.0 0.01 . 
TM/E Yes 0.13 0.05 0.02 0.05 0.13 0.13 
TM/E Yes 0.07 0.03 0.01 0.10 0.15 0.07 
TM/E Yes 0.10 0.02 .07  
TM/E Yes ND .13  
TM/E Yes 0.13 0.04 0.02 0.13 0.14 0.13 
142 Sal Yes 0.11 0.15 0.05 0.13 0.11 0.11 
143 Sal Ye
130 TM/E No 0.11 0.05 0.08 0.11 0.15 0.11 
134 0.07 
0.14 0.05 0.08 0.13 0.19 0.14 
5  0 0.14 0.07 
145 M/E No 
147 
123 .03 2 . 0.03 
124 
125 
133 0.15 
0.08 0.02 
 0 0.24 0.15 
141 0 0.14 0.08 
146 
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T  A aw  val r serum in A (µg/mL) concentrations in growing 
steers. 
 
D 24 D 26  28  
121 Sal No 0.20 0.21 0.22 0.26 0.26 0.20 
able -10. R  data ues fo  vitam
Id Trt Tran D 0  D D 35 D 56 
126 Sal No 0.19 0.17 0.20 0.14 0.21 0.19 
128 Sal No 0.13 0.18 0.23 0.19 0.22 0.13 
132 Sal No 0.16 0.18 0.21 0.21 0.13 0.16 
135 Sal No 0.25 0.29 0.25 0.28 0.21 0.25 
139 Sal No 0.21 0.24 0.22 0.22 0.21 0.21 
140 Sal No 0.26 0.23 0.24 0.22 0.19 0.26 
122 Sal Yes 0.24 0.18 0.15 0.08 0.19 0.24 
127 Sal Yes 0.24 0.25 0.23 0.26 0.27 0.24 
129 Sal Yes 0.23 0.23 0.23 0.24 0.31 0.23 
136 Sal Yes 0.17 0.14 0.15 0.16 0.18 0.17 
142 Sal Yes 0.18 0.21 0.16 0.22 0.21 0.18 
o 0.26 0.69 0.17 0.22 0.22 0.26 
134 TM/E No 0.26 0.10 0.15 0.22 0.21 0.26 
TM/E  0.32 0.13 0.15 0.22 0.21 0.32 
TM/E No 0.22 0.10 0.13 0.23 0.19 0.22 
TM/E Yes 0.11 0.09 0.13 .  
TM/E Yes 0.32 0.09 0.11 0.10 0.21 0.32 
TM/E Yes 0.17 0.10 0.12 0.17 0.19 0.17 
TM/E Yes 0.24 0.09 0.10 0.09 0.21 0.24 
TM/E Yes 0.22 0.10 0.10 0.21 0.18 0.22 
TM/E Yes 0.25 0.10 0.11 0.23 0.18 0.25 
143 Sal Yes 0.25 0.19 0.19 0.22 0.24 0.25 
130 TM/E N
131 TM/E No 0.24 0.13 0.11 0.11 0.20 0.24 
145 No
147 
123 . 0.11
124 
125 
133 
141 
146 
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T  A a a val r lymph  proliferation to PHA (stimulation index.) 
i w r
 
 
121 Sal No 47.12 89.50 10.50 0.65 13.75 
able -11. R w dat ues fo ocyte
n gro ing stee s. 
Id Trt Tran D 0 D 7 D 28 D 35 D 56 
126 Sal No 0.06 57.57 0.08 2.16 7.55 
128 Sal No 1.97 12.25 99.58 1.23 0.73 
132 Sal No 0.33 0.98 0.73 1.51 2.36 
135 Sal No 2.85 66.98 0.29 1.29 4.00 
139 Sal No 0.76 1.09 0.73 1.82 0.64 
140 Sal No 11.66 2.26 4.43 3.09 2.97 
122 Sal Yes 1.99 0.64 1.00 0.70 2.18 
127 Sal Yes 0.94 2.56 167.93 0.95 1.54 
129 Sal Yes 0.80 1.05 2.76 5.98 1.86 
136 Sal Yes 0.04 78.71 2.35 1.47 2.23 
142 Sal Yes 1.69 1.67 1.39 1.23 0.82 
143 Sal Yes 0.86 7.92 2.25 1.56 3.36 
No 2.39 1.41 1.35 0.81 3.73 
145 TM/E 1     
TM/E No     
TM/E Yes   
TM/E Yes 1    
TM/E Yes 2    
TM/E Yes     
TM/E Yes 1    
TM/E Yes     
130 TM/E No 0.85 31.76 0.99 1.26 1.88 
131 TM/E 
134 TM/E No 0.20 3.30 4.03 1.03 2.49 
No 2.43 7.70 1.03 0.93 0.83
147 0.60 0.42 0.09 1.45 2.02
123 1.79 9.36 3.11 . . 
124 0.08 04.88 1.42 1.08 9.42
125 0.40 8.45 0.68 3.11 2.08
133 1.48 1.55 0.60 1.34 2.29
141 1.76 4.51 0.13 1.05 1.63
146 0.60 0.42 0.09 1.45 2.02
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T  A a ta va r lymph  proliferation to OVA (stimulation index) 
i w r
 
 
able -12.  R w da lues fo ocyte
n gro ing stee s. 
Id Trt Tran D 0 D 7 D 28 D 35 D 56 
121 Sal No 1.05 1.08 2.07 0.84 1.90 
126 Sal No 0.04 1.20 0.12 1.29 0.97 
128 Sal No 0.34 1.26 0.88 2.60 0.83 
132 Sal No 0.42 0.38 0.72 1.00 2.10 
135 Sal No 0.60 2.51 0.11 0.83 1.09 
139 Sal No 0.31 0.41 0.52 1.07 0.87 
140 Sal No 1.31 0.68 4.06 0.99 1.12 
122 Sal Yes 1.21 0.34 1.16 0.73 0.69 
127 Sal Yes 0.51 0.88 5.34 0.81 2.56 
129 Sal Yes 0.60 0.44 1.63 5.62 0.95 
136 Sal Yes 0.08 1.92 1.27 1.39 0.88 
142 Sal Yes 0.80 1.26 0.25 1.04 0.77 
143 Sal Yes 0.46 4.35 0.87 1.26 1.81 
130 TM/E No 0.51 0.50 0.45 1.77 1.03 
131 TM/E No 0.68 0.83 0.20 0.95 1.33 
0.36 1.01 0.53 0.41 0.83 
123 TM/E Yes  0 69 . . 
TM/E Yes  4 .32 0.58 1.
TM/E Yes  4 .86 1.14 0.
TM/E Yes  9 .26 1.32 1.
TM/E Yes  2 .07 0.95 0.
TM/E Yes  5 .13 0.77 0.
134 TM/E No 0.28 1.32 0.41 0.54 0.59 
145 TM/E No 
147 TM/E No 1.15 0.14 0.39 1.32 . 
1.29 2.9 1.
124 0.14 1.3 0  35 
125 0.69 1.4 0  97 
133 0.73 0.1 0  07 
141 0.53 0.7 0  94 
146 1.15 0.0 0  64 
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Table A-13. Raw data values for lymphocyte proliferation to KLH (stimulation index) in 
growing steers. 
 
Id Trt Tran D 0 D 7 D 28 D 35 D 56 
121 Sal No 2.05 0.63 1.73 0.39 1.57 
126 Sal No 0.08 1.69 0.12 2.02 0.95 
128 Sal No 0.62 0.86 3.03 0.91 1.02 
132 Sal No 0.19 1.08 1.16 1.47 0.60 
135 Sal No 1.11 2.08 0.15 1.09 5.28 
139 Sal No 0.75 1.91 0.42 1.15 0.75 
140 Sal No 1.71 1.06 2.18 1.24 1.15 
122 Sal Yes 1.09 0.71 0.81 1.06 0.82 
127 Sal Yes 0.74 1.03 2.80 0.69 0.93 
129 Sal Yes 1.14 0.48 2.54 5.97 1.20 
136 Sal Yes 0.03 1.85 2.64 1.18 1.08 
142 Sal Yes 0.64 0.95 0.48 0.78 0.69 
143 Sal Yes 1.37 3.21 0.89 1.13 1.68 
130 TM/E No 1.03 0.78 1.27 2.14 0.89 
131 TM/E No 0.98 0.63 0.83 1.00 1.36 
134 TM/E No 0.38 1.45 0.65 0.60 1.10 
145 TM/E No 0.72 1.44 0.70 0.50 0.82 
123 TM/E Yes 0.96 3.84 1.64 . . 
124 TM/E Yes 0.08 1.38 0.45 0.73 1.14 
125 TM/E Yes 1.69 0.79 0.80 0.70 1.29 
133 TM/E Yes 1.18 1.21 1.35 1.02 1.54 
141 TM/E Yes 1.23 0.46 0.25 0.95 0.68 
146 TM/E Yes 0.88 0.27 0.43 1.43 0.98 
147 TM/E No 1.52 0.04 0.25 1.34 . 
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Table A-14. Raw data values of rectal temperature (ºC) following LPS inoculation in 
growing steers. 
 
Id Trt Tran H 0† H 1 H 0.5 H 2 H 3 H 4 
121 Sal No 38.4 39.0 39.3 39.2 39.8 40.0 
126 Sal No 38.5 39.0 39.2 39.4 39.1 39.5 
128 Sal No 38.6 38.5 39.7 40.3 40.1 40.1 
132 Sal No 38.7 39.2 39.6 39.6 39.6 39.6 
135 Sal No 39.3 39.8 40.0 40.0 39.5 39.1 
139 Sal No 38.0 38.2 38.8 38.6 39.4 39.4 
140 Sal No 38.9 39.7 40.0 40.2 39.8 39.3 
122 Sal Yes 38.7 39.1 39.5 39.7 39.2 39.1 
127 Sal Yes 38.4 38.5 38.6 39.1 39.2 39.6 
129 Sal Yes 38.6 38.7 38.7 39.4 39.9 40.3 
136 Sal Yes 38.3 38.1 38.5 39.1 40.1 39.9 
142 Sal Yes 38.3 38.8 39.1 39.6 40.7 40.0 
143 Sal Yes 38.8 39.2 39.1 39.7 39.3 38.8 
130 TM/E No 39.3 39.7 40.1 40.2 40.7 40.3 
131 TM/E No 38.7 39.1 39.4 39.6 40.2 40.0 
134 TM/E No 38.8 39.0 39.7 39.8 40.4 40.3 
145 TM/E No 39.2 39.8 40.3 40.5 40.5 40.6 
147 TM/E No 40.1 40.3 40.3 40.6 41.1 41.0 
124 TM/E Yes 39.0 39.3 39.4 39.8 39.6 39.3 
125 TM/E Yes 38.3 39.1 39.2 39.2 39.7 39.6 
133 TM/E Yes 38.7 39.0 38.7 39.9 39.6 39.7 
141 TM/E Yes 38.7 38.9 39.1 39.8 40.2 40.2 
146 TM/E Yes 38.9 39.2 39.7 39.8 40.4 40.0 
123 TM/E Yes 39.7 40.2 40.3 40.0 39.0 39.2 
†Hours post inoculation 
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Table A-14 (Cont.) 
 
Id Trt Tran H 6† H 8 H 12 H 24 H 48 
121 Sal No 38.7 38.7 38.8 38.5 39.1 
126 Sal No 39.2 39.0 38.1 38.8 38.6 
128 Sal No 39.2 39.1 39.6 38.5 39.0 
132 Sal No 38.8 38.5 38.5 38.7 39.0 
135 Sal No 38.8 39.4 39.5 40.0 39.0 
139 Sal No 38.5 38.1 38.6 38.6 38.8 
140 Sal No 39.0 38.7 39.5 38.4 38.9 
122 Sal Yes 39.2 39.1 39.6 38.7 38.8 
127 Sal Yes 39.2 38.8 39.6 38.3 38.7 
129 Sal Yes 38.8 38.6 39.1 38.6 38.9 
136 Sal Yes 38.8 38.5 38.9 38.3 38.8 
142 Sal Yes 39.6 38.8 39.0 38.6 39.3 
143 Sal Yes 39.3 39.2 39.5 38.5 39.1 
130 TM/E No 38.9 38.6 39.1 39.3 39.3 
131 TM/E No 39.2 39.0 39.5 39.2 39.5 
134 TM/E No 39.0 39.0 39.0 38.8 39.4 
145 TM/E No 39.3 39.5 39.5 39.2 39.8 
147 TM/E No 39.5 39.5 39.5 39.5 39.7 
123 TM/E Yes 38.6 . . . . 
124 TM/E Yes 39.7 39.2 41.1 38.8 38.7 
125 TM/E Yes S 38.7 39.3 39.2 38.8 
133 TM/E Yes 38.5 38.8 39.3 38.4 39.2 
141 TM/E Yes 39.0 38.5 38.9 39.1 39.0 
146 TM/E Yes 39.0 38.8 39.1 39.4 39.3 
†Hours post inoculation 
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Table A-15. Raw data values for humoral antibody titer to KLH (% positivity) 
concentrations in growing steers. 
 
Id Trt Tran D 0 D 14 D 21 D 35 D 42 D 49 D 56 D 63 
121 Sal No 50.26 40.92 33.26 42.13 57.03 47.21 50.52 45.76 
126 Sal No 45.83 44.55 41.05 45.28 55.47 47.54 59.64 43.16 
128 Sal No 40.63 46.73 47.05 41.65 38.02 47.86 54.95 47.70 
132 Sal No 65.10 56.42 64.74 51.82 66.93 72.85 73.96 67.50 
135 Sal No 50.52 63.92 43.97 39.47 64.58 61.17 68.75 62.14 
139 Sal No 51.56 49.39 44.13 48.67 60.94 63.76 57.29 34.23 
140 Sal No 50.52 62.23 41.37 73.85 68.75 63.60 76.30 44.13 
122 Sal Yes 66.41 55.45 67.17 53.51 58.07 76.74 70.31 72.15 
127 Sal Yes 52.60 48.43 44.13 48.67 60.68 59.22 33.90 55.00 
129 Sal Yes 56.77 47.46 40.24 52.78 52.08 70.09 55.99 54.00 
136 Sal Yes 42.45 36.56 45.59 65.38 60.68 55.81 53.39 48.67 
142 Sal Yes 44.79 40.68 38.62 36.56 50.52 49.32 50.00 58.60 
143 Sal Yes 66.15 49.64 50.95 44.55 53.13 74.96 108.1 59.08 
130 TM/E No 51.04 50.61 43.81 48.91 56.51 61.82 58.33 74.82 
131 TM/E No 33.59 52.06 38.94 46.97 59.64 67.82 61.20 45.59 
134 TM/E No 46.61 55.45 40.89 55.21 51.56 67.33 55.73 55.98 
145 TM/E No 50.00 53.27 44.94 50.61 52.86 57.27 53.65 47.22 
147 TM/E No 57.81 57.14 37.64 46.73 62.50 56.79 55.21 38.94 
123 TM/E Yes 38.02 53.51 42.02 . . . . . 
124 TM/E Yes 59.90 55.21 40.89 55.69 69.79 61.17 56.51 55.69 
125 TM/E Yes 44.27 54.72 43.00 46.00 72.66 59.38 52.60 38.29 
133 TM/E Yes 48.70 66.34 42.18 57.14 63.54 85.34 72.14 56.95 
141 TM/E Yes 47.92 44.79 36.67 41.40 54.69 71.71 58.59 46.97 
146 TM/E Yes 40.10 44.55 56.30 56.66 69.79 76.74 60.16 74.82 
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